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Under fluid shear stress, the cytoskeleton and small GTPases like Rho, Rac and Cdc42 
undergo several changes and modulate the expressions of certain genes such as JNK, NF-κB 
ICAM-1 and Runx2. Short term activation of these contractile proteins and the early 
expression of the osteogenic differentiation markers have been studied previously, however, 
the relationship between contractility and shear stress mediated differentiation remains 
unclear. Here, we hypothesize that applied shear stress can induce changes in the contractility 
and shape of a stem cell, and hence regulate its lineage determination.   
After 48 hours, continual exposure of human mesenchymal stem cells to laminar fluid flow 
showed increased expression of the osteogenic markers. These cells were observed to show 
maximum differentiation when they were subjected to shear stresses between 1-1.5 Pa. From 
the Non-muscle myosin IIA (NMMIIA) and RhoA expression, an increase in contractility of 
the cell was measured with time. However, when cell contractility was disrupted by 
NMMIIA or actin inhibitors, the osteogenic marker expression was not observed. This 
indicates a clear relationship between cell contractility and shear stress modulated stem cell 
fate. Thus, it is now important to understand whether shear stress affects contractility and in 
turn regulates stem cell fate or they act independently. For this, fluid shear stress was applied 
on cells grown on different topographies allowing varying spreading areas of cells, thus, 
permitting them to have different contractility inherently (high and low). Cells with higher 
contractility also showed augmented NMMIIA and RhoA expressions upon fluid flow 
exposure. Subsequently, it was observed that cells with low contractility remained 
multipotent, while the ones having higher contractility followed osteogenic lineage. 
Importantly, when treated with pharmamological inhibitors of actomyosin contractility, cells 
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with higher contractility also did not differentiate. These results suggest that shear stress 
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In this chapter, the importance of studying the differentiation of Mesenchymal Stem Cells 
(MSCs) will be discussed. We will also put some light on the physical microenvironment of 
MSCs and how the response and fate of stem cells are influenced by their surroundings. This 
will lead us to recognize the significance of fluid shear stress in deciding the fate of MSCs 
and identify the unanswered questions in the field, which will thus help us in forming the 
hypotheses for this thesis. Finally, formulated objectives towards answering the hypothesis 
will be detailed. 
1.2. Why study Mesenchymal Stem Cells differentiation? 
Many adult tissues have been found to be populated by group of stem cells with the capability 
to self-renew and to differentiate on being stimulated by trauma, disease or aging. MSC is 
one such multipotent adult stem cell capable of differentiating into multiple lineages [1].   
This cell type was first identified and isolated as a rare population of nucleated plastic-
adherent stromal cells from bone marrow [2]. Since their identification, MSCs have been 
isolated from almost every type of connective tissue. They are spindle shaped, heterogeneous 
population of cells with variable growth potential and often described as colony-forming unit 
fibroblasts [3]. Beyond the morphological identification, MSCs are identified by expression 
of surface markers CD44, CD71, CD73, CD90 and CD105 and by the absence of CD34, 
CD45, CD14, CD80, CD86 and CD40 [4]. However, there is variability in the expression of 
these markers owing to species differences, tissue sources and culture conditions. 
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In quiescent stage, MSCs are protected from any DNA damage and  upon stimulation by 
surrounding factors, MSCs differentiate to regenerate mesenchymal tissues such as bone, 
cartilage, adipose, muscle, ligament, tendon and stroma [1, 2, 5, 6]. Due to their ability of 
self-renewal and differentiation into several functional and viable cell types, MSCs are 
treated as promising source for cell-based therapeutic methods, including applications in 
osteogenesis imperfecta [7], hematopoietic recovery [8] and bone tissue regeneration [9]. 
Notably, these cells can also be directly obtained from the diseased individuals, thus, 
preventing immune rejection. Hence, MSCs are in high demand in the field of cell-based 
therapeutics. Despite increasing information related to MSCs and their benefits in cell-based 
approaches, the mechanisms that regulate MSC self-renewal capacity and multilineage 
differentiation processes is still elusive and intrigues active research.  
1.3. Niche of Mesenchymal Stem Cells 
Stem cell survival, self-renewal and fate determination is significantly controlled by the stem 
cell niche, which is formed by several niche factors including growth factors, cell-cell 
contacts and cell-extracellular matrix (ECM) interactions (Fig.1.1). Thus, it is important to 
understand the interactions between these niche factors to identify the conditions required for 
making the stem cell response more robust for therapy.  
Growth factors are often effective in directing stem cell fate [10, 11]. This effect could be 
autocrine or paracrine. Depending on the growth factors present in the surroundings, genetic 
alterations can take place in stem cells, thus switching between maintaining the quiescent 
stage and activating their differentiating processes. 
Besides the secreted growth factors by the stem cells and the stromal cells, biochemical 
signals are also contributed by extracellular matrix components of the stem cell substrate. 
Specific integrins, present at the cell surface, interact with the underlying extracellular matrix 
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and  regulate proliferation and lineage induction [11, 12]. However, chemical cues do not act 
alone in controlling stem cell behaviour. Physical components of the niche supplement the 
effects of the chemical niche to do that.  
Figure 1.1. Illustration representing detailed niche of mesenchymal stem cell showing cell-cell 
adhesion, cell-substrate interactions and growth factors. Components of stem cell niche interact with 
each other and influence stem cell fate. Chemical gradients formed by fluid flow and the source of 
secretion also affect cell behaviour. [Modified from [11, 13]] 
 
In the bone marrow, MSCs characteristically inhabit in fenestrated sinusoidal capillaries 
formed by perivascular niche. The endothelial fenestrations constituted by the cells of 
sinusoid walls form nanoholes and provide topographical influence to MSCs [14].  In vitro 
experiments suggest that physical properties of synthetic materials, including substrate 
rigidity [15, 16] and micro- and nano-topography [17–19], correlate with MSC differentiation 
by influencing alterations in cell shape and actin cytoskeleton.  
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The physical niche of MSCs also consists of flowing fluid which applies force on the stem 
cells and generate deformations. During cyclic mechanical loading and unloading of bone, 
fluid shear stress is established in interstitial pockets surrounding the bone cells [20, 21]. A 
slight alteration in the mechanical environment can trigger signalling pathways involved in 
differentiation process. Just 5% substrate strains can induce MSCs to differentiate to smooth 
muscle cells [22]. Similarly, multiple intracellular signalling pathways get stimulated upon 
exposure of stem cells to mechanical forces generated by fluid shear stress.   
1.4. Motivation of the thesis 
Stem cells act towards applied fluid shear stress initially by proliferating in the niche [23–25] 
and eventually, by differentiating and contributing to the surrounding environment [26–32]. 
They undergo several changes due to altered genetic expression and protein translation. One 
such change is the reorganization of the actomyosin cytoskeleton and altered expression of 
the related proteins.  The up- and down-regulation of many of these molecules is known to 
regulate the intracellular contractility of the stem cells. However, the connection between the 
shear stress mediated intracellular contractility and lineage specification of stem cells still 
remains elusive. Additionally, the intricate mechanism involved in the phenomenon is not 
well understood. Thus, it is important to understand: 
(i) Whether shear stress and cellular contractility impinge on one another leading to 
stem cell fate determination or do they work independently? 
(ii) Does the stem cell fate, directed by fluid shear stress, get altered upon modulating 
intracellular contractility? 
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1.5. Hypothesis and Thesis outline 
In this thesis, we hypothesize that applied shear stress can induce changes in 
contractility and shape of stem cell, and hence regulates its lineage determination. 
Depending upon the microarchitecture of the extracellular matrix proteins, the contractility 
and the fate of stem cells can be fine-tuned. We also postulate that fluid shear stress mediated 
stem cell differentiation varies with the underlying extracellular matrix topography, which 
serves in modulating the contractility of the cells.  
hMSCs, which are one of the most well studied and a highly potent stem cell type for cell 
based therapy in humans, will be used to answer the aforementioned hypotheses. To address 
the concerned questions, two main set of experiments will be performed using hMSCs as the 
model cell type. 
Firstly, we will identify the lineages adopted by hMSCs under fluid shear stress mediated 
differentiation and the cellular changes involved in the process of lineage determination. 
Following are the objectives for this part of thesis:  
1. To recognize the lineage of differentiation of hMSCs under fluid shear stress. By 
identifying the lineage, we will be able comprehend the mechanism of shear stress 
mediated differentiation of stem cells. 
2. To elucidate the change in cellular contractility at the molecular level under fluid 
flow. Hence, we will be able to attain a better understanding of the pathways involved 
in stem cell fate determination under physical stress. 
3. To establish a connection between the fluid shear stress mediated lineage 
determination and changes in cellular contractility using pharmacological antagonists. 
Thus, we will be able to establish a relationship between fluid shear stress, stem cell 
contractility and its fate.  
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Secondly, we will explore the different fates chosen by hMSCs exposed to fluid shear stress 
under the influence of surrounding extracellular matrix. This physical manipulation of 
topographies of the extracellular matrix will also allow us to vary the basal contractility of the 
cells. Following are the objectives of the second part of thesis: 
1. To identify the effect of topographies on hMSC morphology and contractility. This 
will help us obtain sets of hMSCs with varied basal contractility.  
2. To understand the altered contractility and molecular expressions of MSCs on distinct 
topographies and applied shear stress.  
3. To recognize the interaction of shear stress with topography directed stem cell 
contractility in order to decide the fate of the stem cell. 
This study will help in understanding the biochemical and physical mechanisms involved in 
the shear stress mediated differentiation process of adult stem cells. The biophysical and 
microscopic techniques used in the study will provide answers related to the control of stem 
cell niche at the single cell level. This underlying knowledge of the phenomenon will provide 
a foundation for tissue engineering applications by unravelling the intricate mechanisms in 
adult stem cell microenvironment. This thesis will also provide deeper insights in the 
pathways and mechanisms involved in the stem cell differentiation. However, this thesis will 









2. Literature Review 
 
2.1. Preview 
In this chapter we will first discuss what fluid shear stress (FSS) is and how is it relevant 
physiologically, particularly for stem cells. We will then delve into the cellular response to 
FSS, focussing on stem cell response, and will further lead the discussion on the mechanisms 
of FSS detection adopted by stem cells. After that, the significance of contractility and ECM 
properties in stem cell maintenance and differentiation will be elucidated with subsequent 
review on osteogenesis. The chapter will conclude by highlighting the gap in the current 
knowledge and the reiteration for the focus of this thesis. 
 










Figure 2.1. Fluid shear stress applied in body systems. A. Shear stress applied on the blood vessel 
wall. B. Nature of fluid flow developed inside a blood vessel. [Modified from [33]]  
A B 





Shear stresses are the forces acting parallel to the surface wall that are generated due to 
flowing fluid and are expressed in units of force/unit area (N/m
2
 or Pascal [Pa] or dyne/cm
2
). 
This tangential stress or shear stress is directly proportional to product of flowing fluid 
viscosity and the spatial gradient of flowing fluid velocity at the wall (FSS = µ x dv/dy) (Fig. 
2.1A). The fluid could flow in laminar or turbulent regimes, depending on the velocity of the 
flowing fluid and the roughness of the surface.   
Laminar flow, or streamlined flow, can be undisturbed flow, described by smooth 
streamlines, and disturbed laminar flow can be illustrated by pockets of reversed. In turbulent 
flow, the velocity of flowing fluid at a position changes continuously over time, even though 
there is a steady flow [33–35]. For example, blood flow is pulsatile (unsteady) in nature [33, 
36, 37]. In straight sections of artery, fluid flow is unidirectional and pulsatile with a 
magnitude that fluctuates between 1.5 – 7 Pa. In contrast, in irregular regions of arteries both 
disturbed laminar and pulsatile flow occurs (approximately <10 to 12 dyne/cm
2
) [38–40] 
(Fig.2.1B). Thus, different vascular regions face different type of fluid flow and might also 
have varied response to the shear stress stimuli [41] .  
 
2.3. Fluid flow: Physiological relevance 
In biological systems, fluids are the most primary way of transporting chemical and 
biochemical components. These chemical and biochemical constituents induce autocrine and 
paracrine effects on cells. Along with transportation, the mechanical components of fluid 
flow also play a significant role.  
 





Figure 2.2. Chart categorizing the different flow rates generated in vivo based on their average 
velocity. [Modified from [42]] 
 
Although both chemical carrier and mechanical nature of fluid flow has been found to be 
necessary for morphogenesis of mammalian body, different flow rates create different effects 
at various stages of development (Fig. 2.2). Also, numerous biological mechanisms, from 
development of embryo to remodelling of bones, are influenced by the signalling pathways 
triggered by the varying mechanical forces generated by the moving extracellular body fluid. 
During development of mammalian embryos, fluid flow direction, detected by Nodal cilia, 
has been found to have an important role in deciding left-right patterning of the embryo [10, 
11]. Nodal cilia, in a developing mammalian embryo, are sufficiently tilted towards the 
posterior side. Thus, during rotation, they brush against the posterior surface and do not 
generate enough force, therefore, allowing fluid to flow only in one direction. This initiates a 
signalling cascade throughout the left side of the embryo, leading to the decision of left-right 
patterning [12, 13]. Venous-arterial specification during development also appears to be 
influenced by shear stress. Developed flow patterns change the global architecture of arterial 
and venal organization in embryo, and regulate the expressions of arterial and venous 
markers accordingly [47].  
Once the vascular precursors are formed in developing organisms, as studied in mouse 
systems, blood flows through the vessels generating laminar shear stress of 0-0.55 Pa [48]. In 





developed organisms, plasma, which forms 1/5
th
 of the extracellular body fluid, is controlled 
by cardiac cycle and keeps flowing through the circulatory system. This flowing fluid applies 
shear stress on the inner lining of the vessels, which is formed by endothelial cells. The 
applied shear stress varies throughout the system because of the changes in pressure and 
vessel diameter. Acute changes in mechanical stresses created by blood flow can cause 
immediate alterations in secretion of vasoactive element, e.g. nitric oxide [49]. Chronic 
alterations in mechanical forces may result in permanent changes in arterial wall leading to 
vascular remodelling. Cellular response varies in terms of phenotypic expressions like 
cytoskeletal rearrangement, cell elongation and realignment along the flow direction. There is 
modulation of genotypic expression also by up- or down-regulation of various genes leading 
to varied growth, proliferation and sometimes, differentiation. The change in shear stress 
caused due to hypertension, in the vascular system, sometimes leads to diseases related to 
atherosclerosis also [50]. During blood flow, owing to the hydrostatic pressure generated by 
heart systole, water oozes out from the capillaries into the tissues forming interstitial fluid. 




. However, during 
mechanical loading, interstitial fluid flows at different flow rates from high pressure locales 
to the low pressure locales and apply varied amount of shear stresses on cells residing in the 
tissue [51–53]. 
This interstitial fluid also flows through bone marrow. The cells in the bone marrow are 
exposed to 0.8-3 Pa shear stress created by the interstitial fluid [20]. This fluid shear stress 
may directly affect bone cellular metabolism. In vivo, loading of bone suggests that dynamic 
loading of bone, which enhances fluid flow, induces osteogenic response leading to change in 
local bone mass and architecture, while static loading, which has little flow, does not 
influence osteogenic activity. This indicates that fluid flow affects cellular response on 
loading. Studies suggest that osteocytes are most mechanoresponsive cells in bone, whereas 





osteoblasts and periosteal fibroblasts are relatively less sensitive to mechanical stress [54]. 
The mechanoresponsive nature of bone cells has intrigued the scientists to probe into the 
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Table 2.1. Schematic representation of biological phenomena regulated by fluid shear stress. 
[Modified from [55]–[57]] 





2.4. Cellular response to fluid shear forces 
In a developed organism, blood and interstitial fluid are two major extracellular fluids which 
apply mechanical forces on the cells lining the vessels. The responses of the cells lining the 
endothelium of blood vessel and the cells residing in bone marrow have been studied in 
detail.  
Under physiologic conditions, the mean shear stress exerted on the endoluminal surface by 
blood flow allows the endothelial cells (ECs) to sense and respond to the mechanical stresses. 
Cellular cytoskeleton and other structural components play a critical role in 
mechanotransduction, by transmitting and modulating tension within the cells by focal 
adhesions, integrins, cell-cell junctions and ECM [58, 59]. However, significant variations in 
fluid forces occur in vivo. These changes are associated with phenotypical modulation of the 
smooth muscle cells and the endothelial cells, leading to structural rearrangements of the 
arterial wall [56]. Straight vessels allow laminar flow regime which gets converted to 
disturbed blood flow at vessel bifurcations or curvatures. Shear stress induced by laminar 
flow allows cells to adapt and down-regulate their induced intracellular signalling. On the 
other hand, in disturbed flow, cells are not able to adapt to a continuously changing flow 
pattern [27, 33, 56]. 
Like endothelial cells, fluid flow has been found to be pivotal for the modulation of bone 
mass too. Exercise increases bone mass while unloading due to limited movement, bed-rest 
and weightlessness leads to atrophy of bone mass. This occurs due to fluid flow mediated 
induction of signalling pathways involved in mechanical loading-stimulated and injury-
influenced remodelling [21]. In vitro studies on osteoblasts have found that skeletal 
unloading leads to augmented bone resorption [60], diminished bone mineral density [60], 
decreased bone formation [61, 62], restricted bone growth and strength [39], and inhibited 
mineralization [61]. On cellular scale, mechanical unloading causes decreased osteoblast 





number [61–63], reduction in osteoblast size [62], and decrease in mineral apposition rate 
[61]. Upon activation by fluid shear stress, osteoblastic and osteocytic cells exhibit 
intracellular Ca2+ mobilization [64], release of prostaglandin E2 (PGE2) [65], increase in 
osteopontin (OPN) gene expression [66], augmented mitogen-activated protein (MAP) kinase 
activity [66], and inhibited NF-κB DNA binding [67]. Osteoblasts also demonstrate 
controlled expression of proteins, such as cyclooxygenase-2 (COX-2) and prostaglandin E2 
(PGE2), which are involved in regulating formation and resorption of bone. Additionally, 
osteoprogenitors are also believed to be regulated by loading induced fluid shear stress, once 
they are employed to bone formation sites [23]. These studies suggest that, along with 
boosting nutrient transport to individual cells embedded deeply within bone matrix; bone 
fluid flow influences cellular functions too, subsequently, resulting in remodelling of bone 
architecture. 
Knowing that cells detect and respond to fluid flow applied shear stress, both at phenotypic 
and genotypic levels, leads us to several questions: Do stem cells, residing in blood vessels 
and bone, respond to these mechanical forces in similar fashion as that of chemical cues? 
Does shear stress modulate the fate decision mechanism of these stem cells? Which 
mechanisms are involved in such lineage specification processes? 
Adult stem cells, e.g., endothelial progenitor cells (EPCs) and mesenchymal stem cells 
(MSCs), present in the intima of the blood vessels keep facing shear stress continuously due 
to blood flow. This blood flow follows a unidirectional laminar flow and generates a high 
shear stress in straight parts of arterial walls, while a bidirectional disturbed flow generating 
low shear stress is created at branch points or plaques. Evidences suggest that vascular 
progenitor cells sense these alterations in blood flow and differentiate into endothelial and 
smooth muscle cells thus contributing to angiogenesis and vascular remodelling [56].  





In vitro studies have shown that EPCs respond to shear stress by elongating and getting 
oriented in the flow direction and increasing proliferation [68]. Upon being plated on 
Matrigel
®
, post shear stress exposure, EPCs tend to form tubular networks by Day 4 as 
opposed to the cells in static control [47]. A concerted effect of growth factors and shear 
stress on placenta-derived multipotent cells results in a functional and viable endothelial cell 
population within 4 days [69].  
Beside endothelial progenitor cells, there is mounting evidence that shear stresses also 
influence embryonic and mesenchymal stem cell fate determination. Upon shear stress 
exposure of 1 Pa, Embryonic stem cells (ESCs) demonstrate epigenetic changes indicating 
cardiovascular lineage determination [70, 71]. This decision was observed in cells as early as 
24 hr of shear stress exposure [70]. Shear stress is believed to regulate growth factor 
expressions, creating a feedback loop which promotes a specific lineage. In 2003, Illi et al. 
suggested chromatin remodelling to be a key mechanism behind the fluid shear stress (1 Pa) 
dependent changes in gene expression, supported by studies in adult endothelial cells [71]. 
Subsequently, epigenetic changes were linked to the cardiovascular cell fate decision by 
investigating histone modiﬁcation in murine ESC (Embryonic Stem Cell) under flow. Within 
24 hours of laminar flow exposure, cardiovascular markers, including endothelial markers 
VEGFR-2 and PECAM, cardiac marker α-sarcomeric actin, smooth muscle markers smooth 
muscle-α actin and SM22α, and the transcription factor myocyte enhancer factor-2C 
appeared. This study indicated that the laminar shear stress not only promotes cardiovascular 
differentiation of ESCs, but also accelerates the process. Post 24 hour shear stress exposure, 
these ESCs formed tubular-like structures [70]. However, the direct connection between the 
histone modiﬁcation and lineage determination is still unknown.  
Mesenchymal stem cells (MSCs), present in the bone marrow of long bones, are exposed to 
in vivo shear stresses when the bones undergo mechanical loading. About 23% volume of 





bone is filled with fluid which flows outwards across the cortex of long bone attributed to the 
hydrostatic pressure gradient created by medullary pressure. Mechanical bending loads 
increase the flow further by transcortical pumping of the fluid [20]. This flow creates shear 
stresses leading to modifications in cellular behaviour. 
In vitro, the determination of osteogenic lineage has been observed in MSCs on shear stress 
application ranges from 1 to 20 days [29, 72, 73]. Adipose derived MSCs elicit bone like 
responses upon facing pulsatile fluid flow, with mean shear stress of 0.6 Pa and a pulse 
amplitude of 0.3 Pa, after osteogenic induction by 1,25-dihydroxivitamin D3 [74]. Previous 
studies have shown that FSS has multiple effects on hMSCs [71]. Response of hMSCs to FSS 
has been quantified by measuring an increase in the concentration of Ca
2+ 
 at 0.5, 1 and 2 Pa 
[79, 83, 84]. Remodelling of actin cytoskeleton has been reported in hMSCs during 
osteogenic differentiation [76]. Several molecules like Focal Adhesion Kinase (FAK) [25], 
MAPK [28] and RhoGTPases [86, 87]
 
play a significant role in the transducing mechanical 
signals applied by FSS. FSS activates extracellular signal-regulated kinase1/2 (1 Pa) 
(ERK1/2) also, which can trigger numerous transcription factors, such as activator protein1 
(AP-1) and runt-related transcription factor 2 (Runx2) [28, 29]. 
Table 2.2. Summary highlighting the role of fluid flow in progenitor and stem cell differentiation 
Reference Cell Source Highlights  Shear Stress Experiment 






EPC differentiation and 
proliferation in response to 
shear was investigated 
Rotating disc-type flow 
loading device, 0.01-0.25 







 ESC differentiation in 
response to shear was 
investigated 
Parallel-plate flow 
chamber, 0.15-1 Pa up to 
72 hr 
Illi et al., 
2005[70] 
Murine ESC Effects of shear stress and 
histone deacetylase inhibitor 
on cardiovascular lineage gene 
expression was investigated 
Cone-plate apparatus,  
0-1 Pa upto 8 hr 
0-2  
Wolfe et al., 
2012[32] 
Murine ESC  Fluid shear stress directed 
germ lineage specification in 
ESCs was studied 
Parallel plate bioreactor 
system, 0.15-1.5 Pa for 4 
days 












Bone-like response to 
pulsatile shear was tested 
after stimulating osteogenic 
differentiation 
Parallel-plate flow 
chamber, up to 1 hr 
pulsatile flow, peak shear 
stress 8.4 Pa/s 





certain gene expression in 
response to continuous and 
intermittent flow 
Parallel-plate flow 
chamber, 0.23 Pa 
continuous or 
intermittently (5 min 
alternating intervals) 
upto 24 hr 
Zhao et al., 
2007[73] 
Human MSC Proliferation, ECM 
formation, and differentiation 
in 3D constructs in perfusion 
culture were evaluated 
Cell-seeded PET matrix 
in a perfusion bioreactor, 







Proliferation, distribution and 
differentiation in 3D culture 
was evaluated 
Cell-seeded PLGA 
scaffolds cultures in 
spinner flask up to 21 
days 





differentiation of MSCs was 
studied; Intracellular Ca2+ 
mobilization was also 
evaluated 
Parallel plate flow 
chamber, oscillatory fluid 
flow 
Riddle et al., 
2006[25] 
human MSC MAP kinase and Ca2+ 
signaling was identified to 
modulate fluid flow-directed 
stem cell proliferation 
Parallel plate flow 
chamber, oscillatory fluid 
flow at 0.5, 1 and 2 Pa 
Liu et al., 
2012[26] 
human MSC Effects of intermittent and 
continuous FSS on hMSCs 
were evaluated  
Perfusion culture system, 
Intermittent flow at 0.42 
Pa for 1 hr and 0.3 
mL/min for 11 hr; 
Continuous flow at 0.42 







differentiation of MSCs was 
identified  
Parallel plate flow 
chamber, oscillatory fluid 
flow (1Hz) with peak 
shear stresses of 1Pa 





Fluid shear stress induced 
osteogenesis in MSCs was 
studied 
Parallel plate flow 
chamber 0.9-2.2 Pa for 
24 hr 
Huang et al., 
2010[31] 
Bone marrow MSC Fluid shear stress mediated 
cardiomyogenic 
differentiation in MSCs was 
studied 
Parallel plate flow 
chamber 1 Pa for 24, 48 
and 72 hr 
 





2.5. Flow detection at the cellular scale 
Figure 2.3. Detection of fluid shear stress signals by stem cells. 1. Ion channels stretch on fluid shear 
stress application to allow influx and efflux of ions, subsequently, activating the signalling pathways. 
2. Glycocalyx senses torque created by fluid flow on the surface and transmits it to the cytoskeleton 
attached beneath it. 3. Cytoskeleton deforms and applies tension on the cell-cell junction and cell-
ECM adhesions attached to it. [Modified from [42]] 
 
With the knowledge of stem cell response to the applied mechanical signals, it is important to 
understand how these signals are detected by the stems cells. The process of 
mechanotransduction begins with detection of the applied mechanical signals. Ion channels, 
glycocalyx, integrins, and cytoskeleton are considered to be significant sensors of FSS 
induced mechanical signals [88, 89]. These cellular elements transmit the applied mechanical 





signal to apical cell components, such as plasma membrane or the cortical actin, where the 
received signal is transduced or transmitted to the intracellular elements [80]. 
2.5.1. Mechanosensitive membrane channels 
Mechanosensitive membrane channels are gated directly by forces and are involved in either 
converting this mechanical signal into electrical signal or regulating the release of secondary 
messengers that subsequently gate ion channels, which do not themselves, take part in 
sensing mechanical signals. These mechanosensitive channels are particularly important from 
a mechanosensing perspective because they respond rapidly with very short latency period 
(order of milliseconds). FSS-directed cell membrane deformation and membrane protein 







 (Fig.2.3.1). Tenfold increase in intracellular Ca
2+
 concentration has 
been observed in 3-D dynamic cultured and FSS stimulated hMSCs [76]. However, Ca
2+
 
release in adult stem cells is different from that in specialised cells. In osteoblasts, FSS 
induced ERK(1/2) phosphorylation is blocked upon the inhibition of both mechanosensitive 
cation-selective channel and L-type voltage sensitive Ca
2+
 channel [81]. At the same time, 
when hMSCs were treated with pharmacological antagonists of these channels, no significant 
effect on fluid flow mediated Ca
2+
 concentration or ERK(1/2) activation was observed. Major 
source of Ca
2+
 in MSCs is the intracellular Ca
2+
 storage since hMSCs are non-excitable cells 
in undifferentiated form and majorly do not express functional L-type Ca
2+
 channels. Release 
of this intracellular Ca
2+
 is regulated by inositol 1,4,5-trisphosphate receptors (InsP3Rs), 
while Ca
2+
 influx into cells via plasma membrane is primarily regulated by the store-operated 
Ca
2+
 channels and voltage-operated Ca
2+
 currents [81]. Thus, the mode of FSS mediated 
intracellular Ca
2+
 regulation varies in hMSCs and osteoblasts.  





Upon entering the cytosol,  Ca
2+





 signalling, which results in several transcription factor activation, such as 
ΔFosB and FosB associated with osteogenic differentiation [82]. In summary from the above 
discussion, ion channels are believed to be significant mechanosensors for transducing the 
mechanical signals generate by FSS in hMSCs. 
2.5.2. Glycocalyx 
Among the flow sensors, cell glycocalyx has emerged as a significant player in the past 
decade. Glycocalyx is a bush like structure that links matrix to cell membrane proteins and 
lipids. It is composed of proteoglycans and glycoproteins and, it is tightly linked via integrins 
to the underlying cortical cytoskeleton. Thus, they make a 3D quasiperiodic (10-12 nm) 
fibrous meshwork on the cell surface establishing a physical structure to detect the 
mechanical stresses acting on the cell. Primarily observed as a hydrodynamic exclusion layer 
that allows selective interactions of proteins of other cells to the glycocalyx coated cells, it is 
now also viewed as a key transducer of mechanical forces to the underlying cytoskeleton 
[83]. Theoretical modelling of the glycocalyx suggests that it modulates FSS to shield the cell 
membrane [84]. A strain on the extracellular ends of core proteins located at glycocalyx edge 
is believed to be sensed by the stiffness of the glycocalyx core proteins, which undergo 
clockwise rotation and transmit the fluid forces sensed at its tips, via a local disjoining torque 
into an integrated torque in the underlying cortical cytoskeleton [94, 95] (Fig.2.3.2). During 
the process, focal adhesions and stress fibres also break and reform. Hence, two distinct 
signals might be regulating response of glycocalyx to FSS: one is transmitted by core proteins 
of glycocalyx in the form of a torque and another originates from focal adhesions and actin 
stress fibres at the apical and basal membranes of the cells. Glycocalyx-mediated flow 
sensing will thus lead to two major routes resulting either in nitric oxide (NO) production or 





in the cytoskeletal rearrangement by remodelling of both intracellular and extracellular 
matrix-linked junctions [83].  
Most of the evidences for the function of glycocalyx as a mechanotransducer of FSS comes 
from endothelial cells [87]–[89]. Lanctot et al. have identified that glycocalyx is an important 
player in the differentiation of MSCs too [90]. However, further studies need to be done to 
assess whether glycocalyx is also involved in mechanical sensing in hMSCs to sense FSS as 
observed in other cells [91, 100]. 
2.5.3. Cytoskeleton and adhesive mechanosensory receptors 
Most of the FSS responsive cells, such as osteoblasts, osteocytes, endothelial cells and 
hMSCs, have similar outcomes to the applied physical stresses. Thus, it can be hypothesised 
that common cellular mechanisms regulate cellular response to FSS. FSS mediated ERK 
(1/2) phosphorylation in osteoblasts, endothelial cells and hMSCs, is one such response [54, 
88, 101]. Activated ERK1/2 can, subsequently, stimulate transcription factors, such as AP-1 
[102–104].  
Integrins are also widely considered as receptors of mechanical signals applied by FSS. They 
act as upstream molecules and work along with other signalling molecules to phosphorylate 
ERK(1/2) [105, 106]. Integrins are transmembrane heterodimeric proteins with two non-
covalently interacting subunits α and β that connect ECM with underlying cell cytoskeleton 
by various actin-related proteins, including vinculin, α-actin, talin and tensin [107, 108]. 
Among the 8 distinct β subunits, β1 is pivotal in FSS-triggered signal transduction and bone 
formation-associated gene expression in osteoblast-like cells. Integrin β1 associates with Shc 
(an adaptor protein containing Src homology domain-2 domain) to activate ERK(1/2), which 
is decisive in fluid flow-mediated induction of osteogenic genes [103, 105]. Integrin αVβ3 
also significantly regulate such responses in osteoblasts [94]. Thus, integrins, owing to their 





direct link with ECM, are involved closely in transducing mechanical stimulations. Similarly, 
integrins are also very critical in the osteogenic differentiation of hMSCs. FSS enhances α5β1 
level in human adipose-derived MSCs [100]. Meanwhile, integrin α5β1 has been shown to be 
critical for osteogenic regulation of MSCs [101]. Thus, it can be concluded that the enhanced 
integrin levels promote osteoblastic lineage in hMSCs.  
Laterally assembled integrins form clusters called as ―focal adhesions‖ (FAs) [98]. These 
FAs are largely believed to be sites of mechano-reception and transduction. Inhibition of 
focal adhesion formation reduces cyclo-oxygenase-2 (COX-2) and PGE2 production, which 
is essential for mechanical stimulation of bone formation [111–113]. Blockage of FAK 
hinders osterix transcriptional activity and prevents osteogenesis in hMSCs. FAK has also 
been demonstrated to be a key player in modulating ECM-directed osteogenesis of hMSCs 
[105]. FSS-triggered cell membrane deformation causes conformational change in 
membrane-associated proteins linking to ECM, focal adhesions, cell-cell junctions and 
underlying cytoskeleton, and, subsequently, results in releasing of protein complexes to 
transduce mechanical signals. Thus, it can be inferred that integrins and associated proteins 
may act as receptors of mechanical signals applied by FSS on hMSCs.  
An important candidate of the mechanoresponsive machinery lies in the cytoskeleton of the 
cell and the proteins associated with it. FSS mediated cell reorientation has been 
demonstrated to include cytoskeletal components, such as actin, microtubules and 
intermediate filaments [58]. Although it undergoes significant remodelling when cell 
experiences fluid shear, there are some evidences that suggest that cytoskeleton can directly 
detect the flow. Cytoskeleton rearranges and the associated structural proteins alter on FSS 
application [115, 116] (Fig.2.3.3). The reorganization of the cytoskeleton is vital for the 
regulation of osteogenesis in hMSCs [108]. During osteogenic differentiation, parallel-





arranged actin stress fibres, which are extended through the cytoplasm change to cortical 
actin organization. Cytochalasin D disruption of actin microfilament at the early stage of 
osteogenesis can reduce Alkaline Phosphatase (ALP) activity in hMSCs. However, the 
microtubule structure does not show any significant change between osteoblast and hMSCs 
[117, 118].  
Thus, one of the primary ways of detecting fluid mechanical stresses by stem cells is the 
modification in their cytoskeleton proteins and that happens to be one of the initial responses 
too. Hence making the cellular cytoskeleton and the proteins attached to it to be one of the 
significant mechanotransducers in the cell. 
2.6. Stem cell contractility: Importance in differentiation 
Cytoskeleton proteins are crucial for detecting and modulating stem cell response to fluid 
shear stress. However, cytoskeletal components are pivotal not only to ensure cell-shape 
stability but cytoskeletal arrangement also regulates stem cell intracellular mechanical 
properties. The cytoskeletal organization varies significantly in specialised cells like 
osteoblasts and undifferentiated cells like hMSCs. On one hand, hMSCs exhibit thick actin 
microfilament bundles or stress fibers, running through the length of the cell and ending at 
focal contacts, while osteoblasts have fewer and thinner actin stress fibers forming a dense 
meshwork of microfilaments. This difference in actin organization of these cell type is 
evident in their cell elasticities: hMSCs are twofold stiffer than that of osteoblasts [109]. 
Thus, actin organization contributes to cortical stiffness of the cells. This intracellular 
stiffness modulates cell contractility and has been shown to be essential for most of the 
cellular processes including, cell proliferation, migration and stem cell differentiation. 
Cytoskeletal contractility has also been established to be a key regulator for tissue 
morphogenesis. Actin cytoskeleton contractility control is a basic, yet vital mechanism for 





molding cell shape changes during development. Developing embryo of D. melanogaster 
experiences first major shape change in gastrulation, where cell-mediated mechanical forces 
have a critical role [110]. Non-muscle myosin II (NMM II) relocates in the embryo to 
regulate tension and compression [119–121]. This control of gastrulation by non-muscle 
myosins requires signalling by the Rho family of GTPases, which influences myosin 
contractile activity. Small GTPase RhoA are triggered by guanine nucleotide exchange 
factors (RhoGEFs), and in turn regulate Rho-associated coiled-coil protein kinase (ROCK), 
which eventually phosphorylates, NMM II and thus results in increased myosin activity [122, 
123]. Gene deletion homologs suggest that in Drosophila, all 3 levels of control are required 
to prevent gastrulation [121, 124, 125].  
Along with cell shape change during gastrulation, nonmuscle myosin drives dorsal closure by 
stimulating purse-string contraction at the leading edge. Even though there are other sources 
to drive the closure, myosin provides most of the forces for the process to occur. NMMII is 
required during the patterning and morphogenesis of the heart too [126, 127].  
Developmental process has been further extended to study the control of processes at cellular 
level by studying in vitro stem and precursor cell differentiation. In the non-physiological 
environment too, the mechanical properties of the materials around the precursor cells are 
closely interlinked with Rho family GTPase signalling and NMM II contraction within cell. 
Since 1970, high cell density is known to promote adipogenesis and chondrogenesis [128, 
129]. Similarly, sub-populations of 3T3 fibroblasts, cultured at higher-density monolayer, 
have been observed to accumulate lipid [121]. Disrupted actin cytoskeleton by cytochalasin 
treatment also promotes stem cell differentiation into chondrocytes. When actin is disrupted 
or cells are cultured at high density, cell spreading is prevented; leading to restriction of focal 
adhesion and stress fibre formation, and contractility is also inhibited [130, 131]. At the same 





time, RhoA and ROCK1 stimulates myosin contraction, which in turn promotes osteogenesis, 
whereas, Rac overexpression, tends to oppose RhoA action and promoted chondrogenesis 
and adipogenesis [132, 133] (Fig. 2.4).  
Figure 2.4. Varied contractile properties of stem cells alter stem cell fate in different lineages. MSCs 
with higher contractility follow osteogenesis or myogenesis, whereas those with lower contractility 
undergo chondrogenesis or adipogenesis. [Modified from [47]] 
 
Micropatterning technique manipulation of cell spreading indicate that hMSCs grown on 
small fibronectin islands are poorly spread and undergo adipogenesis, whereas stem cells 
grown on large fibronectin patterns are widely spread, form stress fibres and undergo 
osteogenesis. Myosin regulated actin contraction activated by small GTPase Rho seem to 
play a pivotal role in differentiation [86, 133]. Also, substrate stiffness controlled stem cell 
differentiation demonstrated that the substrate stiffness governs the internal properties of the 
stem cells and leads to varied stem cell differentiation [16]. hMSCs spread widely on stiff 





substrates and generate high levels of intracellular contractility which coordinates to pull on 
the surface underneath [47]. These changes promote osteogenesis in stem cells. Additionally, 
over-expression of either Rho or ROCK stimulates actin cytoskeleton contractility and 
subsequently triggers osteoblast-related gene expression in cells [28]. Activation of Rho leads 
to phosphorylation of myosin phosphatase, which triggers myosin light chain to augment 
actin cytoskeleton contractility [114], which is critical for the MSCs differentiation [47] 
(Fig.2.5). Moreover, the activated Rho augments Runx2 expression also [28]. Thus, the 
increased contractility of hMSCs promotes osteogenesis, while diminished contractility 
encourages adipogenesis and chondrogenesis.    
Figure 2.5. Intracellular contractility regulates cell processes. Extracellular signals not only propagate 
to nucleus and trigger transcription, but also regulate Rho-GTPase activity. Rac modulates cell 
motility and Rho instigates contraction of stress fibres. Both can stimulate gene expression. [Modified 
from [11]]  
 
Studies have shown that differentiation of myoblasts into myotubes is inhibited by 
cytochalasin and needs phosphorylation of focal adhesion kinase mediated by integrin, RhoA 
signaling, and contraction of myosin [134–138]. In contrast, RhoA or ROCK1 can prevent 





cell fusion and myotube formation preventing myogenesis [139–141]. Thus, myogenesis 
probably needs a balance of signals mediating contractility that alters through the multi-step 
differentiation process. Similarly, the cardiomyogenesis of stem cells need a balance between 
Rho and Rac signalling which changes with time [47, 142, 143] (Fig.2.4). 
In vitro studies of FSS suggest that endothelial cells and MSCs align along the direction of 
the fluid flow in 12-24 hours. As studied in endothelial cells, during this process, the 
cytoskeleton of cell undergoes several changes. Following shear stress, microtubules get 
homogeneously distributed within the cytoplasm. Intermediate filaments occasionally get 
accumulated at the edges. FSS also leads to microfilament bundling and concentration of the 
associated focal contacts in the proximal (relative to flow direction) cell regions. This actin 
cytoskeleton rearrangement regulated cell alignment the flow direction [135]. Along with the 
cytoskeletal proteins, small rho-GTPases, Rac and Cdc42 have been found to be active in the 
downstream regions of the cells. These small GTPases, which are crucial for maintaining the 
contractility of the cells, affect the polarity of the cells leading to global rearrangement in the 
actin organization and also enhance the expression of certain genes like, JNK, NF-κB and 
ICAM-1. Cdc42 manipulates the position of the MTOC leading to the change in the position 
of nucleus [136]. In hMSCs, enhancing the activity of RhoA using Lysophosphatidic acid 
increases the expression of Runx2 (osteogenic marker) and inhibits the expression of PPARγ 
(an early adipogenic marker) under short term (1 hour) exposure to oscillatory fluid flow 
[28]. However, the lineage followed by the stem cells varies with the duration and type of 
shear stresses they are exposed to and also on the type of growth factor used in the flowing 
medium.  





In summary, cell contractility is a critical component of the stem cell fate regulation 
processes. The expression and regulation of the molecules, aiding in generating cellular 
contractility, is crucial during lineage specification in stem cells. 
 
2.7. Stem cell differentiation: A result of ECM-stem cell interaction 
Figure 2.6. ECM regulates stem cell fate via its nanotopographical features or chemical functionality. 
Cell binding affinity to the ECM triggers the subsequent biochemical signal in the cell. [Modified 
from [137]] 
 
By means of cell cytoskeleton, stem cells interact with the neighbouring cells and the ECM 
around them. These niches, formed by cellular and non-cellular components surrounding the 
stem cells, are likely to comprise both chemical (soluble) and physical (non-soluble or 
topographical) characteristics of micro- and nanoscale sizes that help to interact with the 
cytoskeleton though the focal adhesions and regulate the stem cells via cell–matrix and cell–
cell interactions. Thus, a stem cell niche helps in holding the quiescence of stem cells or in 





stimulating their differentiation. The distinct regions of quiescent and self-renewing 
populations are managed by enabling protection against DNA damage when the stem cells 
are not required. This is in contrast to maintenance and expansion of stem cell numbers (self-
renewal) and the capacity to respond to tissue-regenerative need through differentiation. It is 
thought that stem cells respond to tissue demand by producing progenitor (or ‗transit 
amplifying‘) cells, which rapidly proliferate before migrating to the area of need for 
regeneration and (terminally) committing to a functional phenotype [57].  
Integrins, in the form of focal adhesions, interact with the extracellular matrix and initiate 
signalling pathways in the cells leading to activation of cytoskeletal remodelling which 
subsequently influences cell migration, proliferation, growth and also differentiation.  Cells 
get influenced by several properties of the ECM, including stiffness, topography, and 
adhesion-ligand type, density and affinity (Fig.2.6). Along with chemical signals from ECM 
in the form of ligands, physical cues such as topography and stiffness control adhesion and 
influence cellular biochemical signalling. However, both chemical and physical cues affect 
cell phenotype [137]. 
2.7.1. Stiffness 
Elastomeric polymer networks, for example hydrogels, have been usually used, as their 
physical and chemical properties can be manipulated, simply, by adjusting crosslinking 
density in the network. Hydrogels can vary over a range; from very soſt (<1 kPa in elastic 
modulus, consistency similar to a viscous fluid like honey) to rather stiff (~500 kPa, 
comparable to silicone rubber). Poly(acrylamide) (PAAm) hydrogels can also range from 0.1 
kPa (comparable to soſt neural tissue [138]) to 40 kPa (comparable to non-mineralized bone 
tissue [139]) by simply adjusting crosslinking degree with bisacrylamide.  





As discussed in earlier sections, it is well accepted that stiffer surfaces allow larger adhesions 
to form than softer surfaces and, again, allow cells to spread wider. At the same time, softer 
substrates permit less spreading of cells leading and smaller adhesions to form [16, 149].   
hMSCs, cultured in monolayer on collagen-I-coated gels with varying stiffnesses, 
differentiated into osteoblasts (for the stiffest gel, with an elastic modulus of 25 to 40 kPa), 
myocytes (8 to 17 kPa), or neurons (0.1 to 1 kPa). Actomyosin contractility of the cells 
adapted to the stiffness of the gel: the cells spread the most on the hardest surface and 
developed strong focal adhesions. The stiffness directing stem cell differentiation into a 
particular lineage corresponded to the elastic modulus of the tissue in which the hMSCs 
differentiated into these lineages in vivo (Fig, 2.7). For example, the gel stiffness led to 
osteogenesis of hMSCs was in the same range as that of the stiffness of matrix constructed by 
hypertrophic chondrocytes [16]. 
Figure 2.7. Scale representing tissue elasticity corresponding to the cell type specific to it. [Adapted 
from [11]]   
 
2.7.2. Nanotopography  
Various nanolithography methods have been used to manage the size, spacing, shape and 
organizational symmetry of nanoscale features in numerous materials. Studies have shown 
that 30 nm diameter nanopillars, organised in hexagonal or honeycomb arrangements, 
supported human ESC self-renewal [141], and 120 nm diameter nanopits with centre-to-
centre 300 nm spacing supported hMSC expansion when arranged in a symmetric 
configuration [142], and underwent osteoblastic differentiation when asymmetrically 





organized [143]. Parallel microgrooves (10 μM groove width) on the surface of cell-adhesive 
substrates were recently used to improve the efficiency of cellular reprogramming [144]. 
Ordered nanotopographical patterns resulted in lower cell adhesion [154, 155] while 
nanoscale roughness increased cell adhesion and cell response to materials [147]. Thus, 
nanopatterns can be used to direct MSC osteogenesis with comparable efficiency to 
stimulation by chemical induction methods [143].  
In the bone marrow, MSCs normally reside on endothelial cell made fenestrated sinusoidal 
capillaries which are nanoholes typically 100 nm in diameter. 120nm disordered surfaces, 
which are close to 100nm diameter features optimal for osteogenesis, have been found to 
promote osteogenesis [148]. This is also comparable in length and disorder to the disordered 
hexagonal morphology formed by type X collagen at the endochondral ossification sites. 
63nm periodic self-assembling helical amphiphiles also stimulate osteogenic differentiation  
[149]. Thus, several different features sizes and topographies have been found to promote 
osteogenesis in MSCs.   
Nanotopography has also been used to allow embryonic stem cell phenotype retention. 
Highly ordered surfaces made of colloidal crystal microspheres of 120-nm diameter [150] 
allowed phenotype maintenance, whereas a more random arrangement induced differentiation 
[151]. Furthermore, embryonic stem cell response to basic fibroblast growth factor (bFGF) 
has been demonstrated to be affected by nanoscale lattice arrangements [141]. These studies 
suggest that nanoscale microarchitecture is critical in development.  
2.7.3. Chemistry 
Bone comprises of two juxtaposed ECM matrices. First one is the osteoblast synthesised and 
mineralised calcified bone matrix and second one is the marrow stromal cells synthesised 
marrow ECM. Calcified bone matrix predominantly comprises of well-organised type I triple 





helical collagen fibrils, several bone matrix-specific proteins, such as osteocalcin and bone 
sialoprotein, which facilitate bone mineralisation, small leucine rich proteins (SLRPs), such 
as bgn and dcn, fibronectin and several growth factors, including bone morphogenetic 
proteins (BMPs), TGF and insulin-like growth factors [152, 153].  
The marrow ECM is more complex in nature, due to the presence of collagen types I, III, IV, 
V, and VI, and a high proportion of high-molecular-weight proteoglycans like syndecan and 
perlecan, in addition to bgn, dcn, and growth factors [153, 154]. This marrow ECM harbours 
hematopoietic stem cells as well as MSCs which are the source of precursors of bone matrix-
synthesizing osteoblasts, as well as adipocytes and stromal cells that inhabit the bone 
marrow. While it is well known that marrow ECM components like syndecan play a pivotal 
role in hematopoietic stem cell differentiation [155], limited information is available about 
the influence of marrow ECM on MSC differentiation. However, recent developments 
suggest that bgn-deficient mice exhibit MSC reduction and their defective differentiation into 
osteoblasts [156, 157]. This observation strongly indicates a role of the marrow ECM in MSC 
differentiation.  
Increasing evidences show that growth factor availability and integrin signalling could be 
reduced upon reduction in SLRPs, like bgn presence in the microenvironment. This could 
result in diminished autocrine/paracrine growth factor signalling subsequently impairing 
osteoblastic differentiation of the progenitor/stem cells. In the case of the absence of both bgn 
and dcn, which serve as TGF--binding proteoglycans, TGF- is prevented from proper 
sequestration within the ECM [153, 158], leading to increase in available free TGF-, which 
subsequently directly binds to its receptors on bone marrow MSCs. Consequently, MSCs 
switch their fate‘ from growth to apoptosis, resulting in decreased numbers of 





osteoprogenitor cells and eventually diminished bone formation [153, 159]. These findings 
emphasise on the relevance of the MSC microenvironment in controlling its fate. 
Cells interact with these ECM proteins via integrin receptors and non-integrin receptors, like 
CD36 and CD44. This interaction stimulates several biochemical cascades in the cells 
influencing almost all cell functions [160]. Thus, chemistry of the ECM proteins helps the 
cells in recognising the surface and establishes a link between cell responses to the substrate 
properties. 
Table 2.3. Summary of mesenchymal stem cell lineage specification to various ECM stimuli 
Response Mechanical stimuli References 
Osteogenic differentiation Increase in substrate rigidity Engler et al, 2006 
[16]. 
Random nanotopography Dalby et al., 2007 
[143]  
Disordered surface, with 100nm features Oh et al., 2009 
[148] 
Nanoscale periodicity (~63nm) Das et al., 2013 
[149] 
Increase cell area due to adhesion Mcbeath et al., 
2004 [124] 
Collagen I, Vitronectin Salasznyk et al., 
2004 [161]  
Chondrogenic/Adipogenic 
differentiation 
Decrease in substrate rigidity Engler et al. 2006, 
[16] 
Decrease cell area Mcbeath et al., 
2004, Gao et al., 
2010 [77], [124] 




Intermediate substarte rigidity Choi et al., 2012 
[163] 
Neurogenesis Soft substrate rigidity Engler et al., 2006 
[16] 
Anisotropic (line) topography Yim, et al., 2007 
[18] 





2.8. Osteogenesis of hMSCs 
Independent studies, either manipulating stem cell contractility or studying effect of FSS 
suggest that osteoblastic lineage is generally followed by stem cells with increased 
contractility. Thus, for this thesis, it is important to review the pathways and molecules 
involved in osteogenesis.  
2.8.1. Osteogenesis: Relevant molecular players  
 
Figure 2.8. Pathways impinging on Runx2 protein and stimulated by it. [Modified from [164]]. 
 
Signalling pathways that promote MSC osteogenic lineage differentiation generally converge 
on one key transcription factor: Runx2. Runx2 is considered as the chief regulator of 
osteogenesis and is responsible for mediating the effects of several cytokines in determining 
MSC osteogenesis. Other key transcriptional factors also exert effects either independently or 
in association with Runx2.  
Runx family comprises three discrete proteins: Runx1-3, all of which consist of a different α 
subunit associated with the same  subunit[165]. Runx family has a DNA binding domain, 
known as Runt. However, to bind with DNA, Runx proteins form a heterodimer with 
transcriptional coactivator core binding factor  (Cbf; a co-transcription factor). Runx 
family gets involved in various stem cell commitment processes; Runx1 decides 





hematopoietic stem cell differentiation [166], Runx2 controls chondrogenic and osteoblastic 
cell differentiation [167], and Runx3 determines neurogenesis, epithelial differentiation and 
chondrocyte differentiation [171, 172]. Runx2 efficiency (Runx2
-/-
), due to homozygous 
mutation in mice, demonstrates restricted differentiation of osteoblasts and bone and they die 
shortly after their birth [170]. Rescue of such Runx2 null phenotypes, even by the 
overexpression of other osteogenic factors is difficult, which suggests that Runx2 expression 
is essential for osteogenesis bone formation. 
Numerous osteogenic specific pathways converge at Runx2 which activates and determines 
osteogenesis by targeting several genes of varied signalling pathways, including but not 
limited to BMP, Wingless type (Wnt), transforming growth factor-beta 1 (TGF-1), 
Hedgehog (HH), and (Nel)-like protein type 1 (NELL-1) [174–176]. Upon reception of the 
extracellular signals, several factors associate with Runx2 thus forming a multi-component 
transcriptional complex which triggers most of the significant bone related genes. This allows 
Runx2 to directly influence genes such as: collagen I, collagenase 3 (matrix metaloproteinase 
1), alkaline phosphatase (ALP) TGFβ receptor 1, C/EBPδ and RANKL (receptor activator of 
nuclear factor kappa B ligand), osteocalcin, osteopontin, bone sialoprotein [167, 177–182] 
(Fig.2.8).  
Chemical induction and mechanical force application activate particular signalling cascades 
and osteoblastic genes. MEK extra-cellular regulated kinase (MEK/ERK), a branch of the 
mitogen-activated protein kinase (MAPK) pathway, is one such pathway which connects 
mechanosensitive cell surface integrin-ECM interactions and activation of Runx2 [180]. 
Inhibition of the integrin directed MAPK pathway blocked the ECM controlled increment in 
expression of osteocalcin, an osteogenesis marker. Additionally, increased Runx2 





phosphorylation and osteocalcin mRNA was observed in cells (transfected with constitutively 
active MAPK gene) with over active MAPK pathway [183, 184].  
Alkaline phosphatase (ALP), one of the effector proteins of Runx2, is a ubiquitous protein 
and thus not specific to bone. Although ALP function is not very well defined, numerous 
studies indicate that ALP may function as an early marker for onset of osteogenesis. The 
protein levels also get up-regulated as a response to mechanical force application. ALP 
mRNA levels increase within 2 days after stimulation with the advent of osteogenesis (up to 
14 days) [185, 186]. Various mechanical forces and in vitro methods of stress exposure have 
also been demonstrated to trigger this response [167, 185–189].  
Another effector protein of Runx2 is Osteocalcin, which is a matrix protein and one of the 
few bone specific genes [187] and, second to collagen type I, it is one of the most abundant 
proteins in osteoblasts [188]. It is believed to be a significant player in osteoblast progenitor 
cell differentiation, with substantial up-regulation in both mineralisation and matrix synthesis 
[189]. Numerous intracellular factors regulate the gene and several receptor binding sites 
pertaining to varied hormones interact with them. Mechanical forces have been shown to 
regulate osteocalcin mRNA levels. Upon force application, up-regulation of genes can be 
seen in as less as 1-2 days [164], which steadily increases as differentiation progresses[185, 
188]. This regulation of osteocalcin is believed to be mediated by Runx2 protein [164].  
Osteopontin, another matrix protein, is a secreted glycophosphoprotein found within: bone, 
epithelial lining tissues, teeth, kidneys, blood plasma, and breast milk. Thus, Osteopontin 
cannot be regarded as protein specific to bone, although it does execute some bone associated 
functions. In the bone tissue, it is vital for cell adhesion, migration and survival. Malfunctions 
in osteopontin gene (SPP1) can result in tumorigenesis [195, 196]. SPP1 has also been 





observed to respond to physical stresses. Several studies have shown the up-regulation of the 
gene within 9-24 hours of  exposure to external force [72, 195].  
2.8.2. Chemical induction of osteogenesis 
Physical stimulation of hMSCs to undergo osteogenesis is very well described in previous 
sections. Chemical induction is known to act along with mechanical signals for osteogenesis 
activation. Dexamethasone, a member of the glucocorticoid family of steroids, is a synthetic 
hormone that modulates bone morphogenetic proteins (BMPs), which are closely involved 
with stimulation of osteogenesis [193]. -glycerophosphate facilitates phosphate for 
deposition of calcium phosphate [194] and ascorbic acid is necessary for collagen production 
[195]. Rat MSCs undergo osteogenesis upon being triggered by BMPs[30]. 
 
2.9.  Conclusions 
Thus, from above-discussed studies, we understand that the shear stress modulates the 
contractility of the cell by activating the small GTPases, MAPK and ERK (1/2) pathways. 
Also, the oscillatory fluid shear stress enhances the Runx2 expression indicating the onset of 
osteogenesis in hMSCs. Independently, cell surroundings consisting of cell-ECM interactions 
modulate stem cell differentiation. However, effect of FSS on stem cell contractility and fate 
still remains unclear. It is important to understand whether FSS mediated stem cell 
differentiation is independent of the FSS directed contractility changes in the cells or, like 
substrate directed stem cell differentiation, contractility regulates the FSS controlled hMSC 
differentiation. Thus, in this project, we hypothesize that applied shear stress can induce 
contractility and shape change in a stem cell, and hence regulate its lineage determination.  
This thesis will elucidate the relevance of cell contractility in shear stress mediated 
differentiation of hMSCs. Further, to understand the role of contractility of cells, intracellular 





contractility will be influenced using several biophysical methods allowing a control over the 
cell spreading area. ECM properties will be manipulated to achieve such control on the cells. 





3. Differentiation of hMSCs under fluid shear stress 
3.1. Preview 
In this chapter, we will first discuss the fate of hMSCs when exposed to fluid shear stress and 
the need for performing such study. We will then present the experiments done in order to 
answer the question. Next, we will identify the differentiation lineage adopted by hMSCs 
post fluid shear stress exposure for 48 hrs. We will also recognize if the shear stress mediated 
lineage determination is consistent with varied extracellular matrix (ECM) proteins used to 
coat the glass. Finally, we will ascertain the effect of changing shear stress magnitude on 
fluid shear stress mediated differentiation. 
 
3.2. Introduction  
Due to the differentiation potential and availability in adult tissues, hMSCs are poised to be 
an important adult stem cell to be used for cell based therapies. However, with limited 
knowledge in stem cell biology and the impact of the stem cell microenvironment on them, 
usage of stem cells in cell based therapeutics still faces some challenges [196]. Long-term 
safety and efficacy are some of the important questions which still remain unanswered. To 
answer these questions, it is rather significant to understand the differentiation mechanisms of 
these stem cells in the presence of their natural niche.  
hMSCs are predominantly found on the fenestrations formed by endothelial cells in the 
sinusoids of bones [2, 3] and are exposed to changing fluid shear stresses when bones 
undergo mechanical loading [4, 5]. Specialized hMSCs found in vascular systems are 
believed to give rise to endothelial cells or smooth muscle cells depending on the alterations 





occurring in the blood flow [6]. This suggests that the local environment of hMSCs plays an 
important role in fate determination process. 
Studies have suggested that hMSCs‘ response to shear stress varies with the alteration in the 
fluid flow patterns or regimes. Intermittent or oscillatory fluid flows, as opposed to 
continuous fluid flow, independently, lead to osteogenesis in hMSCs [26, 28].  
In vitro, growth factors, along with shear stress have been found to have great influence on 
fate determination process of hMSCs. When treated with vascular endothelial growth factor 
(VEGF) along with fluid flow, MSCs differentiate to endothelial cells. However, in the 
presence of osteogenic supplemented media, hMSCs undergo osteogenesis [199].  
Although there are several studies focusing on the FSS mediated differentiation, the variation 
in cellular responses makes it difficult to ascertain the precise conditions for in vitro shear 
stress mediated differentiation of hMSCs. In this chapter, we will characterize the conditions 
required for the differentiation of hMSCs under the effect of fluid flow by identifying the 
flow regime, amount of shear stress applied and the extracellular matrix involved in the 
phenomenon. 
 
3.3. Experimental methods and design 
 
3.3.1. Channel design and fabrication 
To answer the posed question, laminar flow regime was created using a parallel plate fluid 
flow chamber with the following specifications: 50 mm long, 2 mm wide and 120 µm high. 
They were made of PDMS (Polydimethyl siloxane; Sylgard
®
 184, Dow Corning) and 
mounted on glass coverslips, which acted as bottom for the channels (Fig. 3.1).  





Negative of microfluidic channels were developed using SU-8 on silicon wafers. 1:10 curing 
agent to base ratio of PDMS was homogenously mixed and poured on silanized silicon wafer. 
It was then degassed to remove any micro-bubbles formed during mixing. After removing all 
the bubbles, PDMS was cured for 2 hours at 80
ᴼ
C. Cured PDMS channels were peeled off 
from the wafer and later attached to glass after being treated by plasma in a plasma cleaner 
(Model PDC-002, Harrick Scientific Corp) for 3 minutes. 
 
Figure 3.1. Microfluidic channels made of glass and PDMS. (A) Microfluidic channels were casted by 
PDMS from silanized silicon wafers. (B) PDMS microfluidic channel tops are attached to glass 
coverslips after plasma cleaning. 
 
3.3.2. Silanization of silicon wafer 
Silanization of silicon wafer was performed to make them non-adherent and prevent the 
attachment of PDMS to them. A non-adhesive layer of trichloro(1H,1H,2H,2H-
perfluorooctyl)-silane (Sigma Aldrich) was coated on the wafer surface. Few drops of silane 
was poured into a weighing boat and placed inside a vacuum desiccator with the silicon 
wafers. Silane vapour was created in the dessicator by pumping out air for 15 minutes. Air 
valves of desiccator were then closed and silane was allowed to deposit on the wafer surface 
for an hour. 





3.3.3. ECM coating of microfluidic channels 
Microfluidic channels were coated by ECM proteins before cell seeding. Channels were first 
washed with ethanol and sterilized with UV for 15 mins. They were then washed with 1X 
PBS (Phosphate buffer saline; Sigma-Aldrich) thrice. Thereafter, they were incubated with 20 
μg/ml fibronectin (Sigma-Aldrich), 20 μg/ml collagen I (Bovine; Invitrogen) or 20 μg/ml 
laminin (from Engelbreth–Holm–Swarm murine sarcoma; Invitrogen) for 1 hour. Excess 
protein was then washed away prior to cell seeding. 
3.3.4. Cell Culture and Fluid Flow conditions 
Human MSCs (Lonza Inc.) were maintained in hMSC growth medium (Lonza Inc.) 
supplemented with 1% penicillin/streptomycin (Invitrogen). Passages 1-5 of cells were used 
in the experiments. 1000 cells/cm
2 
were seeded onto the microfluidic channels. Low seeding 
density of cells was used to characterise single cell response to fluid shear stress.  
For flow experiments, osteogenic medium (Dulbecco‘s Minimum Essential Medium 
(DMEM), α-modification (Invitrogen), supplemented with 10% fetal bovine serum 
(Invitrogen), 1% penicillin/streptomycin (Invitrogen), 5 mM β-glycerophosphoric acid 
(Sigma-Aldrich), 10
-2
 µM Dexamethasone (Sigma-Aldrich) and 50 μg/ml L-ascorbic acid 
(Sigma-Aldrich) was used.  
Shear stress of 1 Pa was applied on cells seeded in microfluidic channels. Applied shear 
stress was calculated using Poisuelle‘s Law,    
   
   
 [200], where Q = flow rate, μ = 
viscosity of the fluid, b = breadth of the channel and h = height of the channel. Laminar fluid 
flow was applied on cells using a Peristaltic Pump (Model P720; Instech). A dampener was 
placed before the flow channel to develop a laminar flow. Figure 3.2 shows the fluid flow 
setup. A closed flow circuit was established by pumping the fluid from the reservoir and then 
bringing back to it using TYGON
®
 tubes (Cole Parmer). Formation of a closed loop helped in 





enhancing the paracrine effect of growth factors on differentiation. A bubble trap was placed 
before the sample to prevent the formation of air pockets in the flow circuit. Reservoir, 
bubble trap, dampener and microfluidic sample were placed inside an incubator (37
ᴼ
C and 
5% CO2) to allow conducive environment for cell metabolism and processes (Fig.3.2).  
Figure 3.2. Schematic of the Microfluidic setup. A closed flow circuit was used to allow fluid to flow 
from the reservoir and back to it. The turbulence created in the fluid flow by the peristaltic pump was 
dampened using a dampener. Bubble trap was used to remove the microbubbles formed in the flowing 
fluid. 
 
Cells were placed in the fluidic channel for 24 hours. Fluid flow was then applied on to the 
cells for 48 hours.     
3.3.5. Immunocytochemistry, confocal imaging and quantification 
Post-fluid flow exposure, cells were washed thrice with 1X PBS for 3 mins each and then 
fixed with 4% paraformaldehyde (Sigma-Aldrich) for 20 mins , followed by three washes 
with 1X PBS for 3 mins each. Post fixation, cells were permeabilized with 0.3% Triton X-
100 (Sigma-Aldrich) for 3 mins. Triton X-100 was then washed away by 1X PBS using three 
washes for 3 mins each. After permeabilization, 1% bovine serum albumin (BSA; Sigma-
Aldrich) in 1X PBS was used for blocking for 1 hr. Once blocked, cells were incubated with 
primary antibody of interest in 1% BSA overnight. Primary antibody was washed away by 





three washes using 1X PBS for 3 mins each. To visualise the cells, they were incubated in 
fluorescent dye tagged-secondary antibody in 1% BSA for 1 hour and subsequently washed 
with 1X PBS thrice for 3mins each.  
Primary antibodies used were Anti-CD44 (Abcam) at 1:500, Anti-CD90 (Abcam) at 1:500, 
Anti-CD105 (Abcam) at 1:500, Anti-Runx2 (SantaCruz Biotechnology, Inc.) at 1: 200, Anti-
FLK-1 (Cell Signaling Technologies) at 1:300, Anti-SMA (Cell Signaling Technologies) at 
1:250, Anti-Osteopontin (SantaCruz Biotechnology, Inc.) at 1:200 and Anti-Osteocalcin 
(SantaCruz Biotechnology, Inc.) at 1:200. Alexa Flour
®
 (Invitrogen) secondary antibodies 
were used. For multipotency markers, permeabilization step was skipped. 
Sample was then mounted by Floursafe (Calbiochem) and several positions were imaged 
randomly on Nikon Confocal A1R to obtain data from 100 cells in every experiment. 
Quantification of intensity measurements was performed using ImageJ. Cells were outlined 
as region of interest (ROI) and the integrated density was measured. Corrected total cell 
fluorescence was calculated by subtracting the product of area of the selected cell and mean 
fluorescence of background readings from the measured integrated density of the cell. 
Graphs were plotted as fold change in protein expression. Fold change was calculated as ratio 
of the measured intensity of proteins in cells subjected to shear stress to the measured 
intensity of proteins in cells in static condition. For the experiments performed at different 
time-points, static controls were kept for each time-point.  
To determine the percentage of differentiating hMSCs, the total number of cells and the 
number of cells expressing more than 1.5-fold increase in Runx2 and Osteopontin were 
counted.   





3.3.6. Alkaline Phosphatase Live Staining 
Alkaline Phosphatase (ALP) staining was performed on live cells. Growth medium was 
removed and cells were washed with pre-warmed DMEM (Invitrogen) for 2-3 min. Cells 
were then incubated in 1X ALP Live Stain (Invitrogen) solution for 25 mins. ALP Live Stain 
was removed and cells were washed twice with DMEM with 5 min for each wash. Cells were 
then maintained in DMEM and imaged using Nikon Confocal A1R within 30-45 mins of 
staining. Post visualisation, DMEM was replaced by fresh growth medium or differentiation 
medium.  
Intensity measurement and plotting of graph was same as that of section 3.3.5. 
3.3.7. Alizarin red S staining 
Alizarin Red S staining was performed to visualise extracellular calcium deposition in flow 
channels. After 48 hour of fluid shear stress exposure, cells were cultured in static condition 
for 5 days in the differentiation medium along with the control cells. On day 5, cells were 
washed with 1X PBS and fixed with 5% formaldehyde solution for 15 min. Post fixation, 
cells were rinsed with de-ionized water and incubated with 0.5% Alizarin red S (Sigma–
Aldrich) solution for 30 min. Cells were then rinsed with de-ionized water until the washed 
solution was clear. Cells were imaged after surfaces were air-dried. 
3.3.8. mRNA expression profiles 
Total RNA was isolated from hMSCs, after fluid shear stress exposure, with RNeasy Mini 
Kit (Qiagen) and reverse-transcribed with iScript
TM
 Reverse Transcription Supermix for RT-





Supermix (Bio-Rad) on a Bio-Rad CFX96
TM
 Real-Time PCR Systems. Primers and probe 
sets for ALPL(Alkaline phosphatase; NM_000478), RUNX2 (Runt-related transcription factor 
2,  NC_000006.12), SPP1 (Osteopontin; NC_000004.12), BGLAP(Osteocalcin, 





NC_000001.11), CD44 (NC_000011.10), THY1 (CD90; NC_000011.10), ENG(CD105; 
NC_000009.12) and GAPDH (GAPDH; NC_000012.12) were purchased from AIT Biotech. 
qPCR was performed with following conditions: 95°C for 30 sec, followed by 40 cycles at 
95 °C for 3 sec and 58 °C for 4 sec. ΔCt was then calculated with respect to the loading 
control (GAPDH) for each sample; ΔCt gene of interest was normalised to that of the control 
(static condition) to obtain ΔΔCt. The fold change in the expression of the gene was 




Table 3.1. List of primer sequences used for qPCR 
Gene Forward Primer  Reverse Primer  
GAPDH CTTTGTCAAGCTCATTTCCTGG TCTTCCTCTTGTGCTCTTGC 
ALPL GATGTGGAGTATGAGAGTGACG GGTCAAGGGTCAGGAGTTC 
RUNX2 TTCACCTTGACCATAACCGTC GGCGGTCAGAGAACAAACTAG 
SPP1 AGGCTGATTCTGGAAGTTCTG CTTACTTGGAAGGGTCTGTGG 
BGLAP TGACGAGTTGGCTGACCA AGGGTGCCTGGAGAGGAG 
CD44 ACCCAAATCATTCTGAAGGC ACCTTCATCCCAGTGACCTC 
THY1 CCTAGTGGACCAGAGCCTTC CAGTTCACCCATCCAGTACG 
ENG CTCTCTGGGCCTTGAGTTTC ACCGTCTCTGGGTTCAAATC 
 
3.3.9. Statistical Analysis 
Each experiment was performed at least three times. Student unpaired t-test was then used to 
perform statistical analyses. Data presented here signify the mean  SD for independent 
experiments (n=3 or 4). Statistically significant data was considered only at p <0.001, p<0.01 
or p<0.05. 





3.4. Results and Discussion 
3.4.1. Fluid shear stress mediated differentiation 
Cells were seeded on 20 µg/ml fibronectin coated microfluidic channels. Shear stress of 1 Pa 







Figure 3.3. hMSC multipotency diminished upon shear stress exposure. A. Immunostained images of 
hMSC multipotency markers showed reduction after fluid flow. B and C. Quantification of protein 
and mRNA expression of multipotency markers in static and shear experiencing hMSCs. 90 cells 
were counted in 4 independent experiments each. mRNA expression was normalised over GAPDH 
expression of the cells. p<0.05 
 
First, hMSC multipotency was assessed after subjecting them to fluid shear stress. Cells were 
immunostained for multipotency markers, CD44, CD90 and CD105. Fig. 3.3 depicts that 
expressions of CD44, CD90 and CD105 were reduced by 0.6-, 0.8- and 0.75-fold, 
respectively, arising from fluid flow exposure. These results were substantiated by 
quantification of genetic expression of the markers by qPCR. There was 0.7-, 0.8-, 0.7-fold 
decrease in genetic expression of CD44, THY1 and ENG, genes of multipotency markers. The 
cells were considered to be losing multipotency due to reduction in the protein expression 
(<1-fold) upon shear stress exposure. This reduction in the expression of the multipotency 
markers could be a result of the preparation of cells towards differentiation instead of self-
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renewal. These results indicate the initiation of differentiation processes in hMSCs upon 












Figure 3.4. Increase in early osteogenic markers when hMSCs were subjected to fluid flow. A. Protein 
expressions of endothelial cell marker (FLK-1) or smooth muscle cell marker (SMA) remained same 
as that of static cells. B Alkaline Phosphatase (ALP) and Runx2 expression increased on shear stress 
application. C and D. Protein and mRNA expression of early markers show many-fold increase. 80 
cells were counted in 4 independent experiments each. Protein expression was normalised over the 
cell spreading area. mRNA expression was normalised over GAPDH expression of the cells. p<0.005 
 
To confirm stem cell differentiation under effect of fluid shear stress, hMSCs were 
immunostained for several early markers of osteoblasts, endothelial cells, smooth muscle 
cells. As can be seen in figure 3.4, cells were positive for osteogenic markers and showed no 
expression of endothelial cell marker (FLK-1) or smooth muscle cell marker (SMA). On 
quantification of image intensity of early markers, cells showed 3.1-folds increase in Runx2 
and 2.8-fold increase in Alkaline phosphatase (ALP) protein expression. mRNA 
quantification showed 2.9- and 3.5-fold increment in genetic expression of RUNX2 and ALPL 
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genes. The cells are considered to be expressing osteogenic markers since the expression of 
the markers is more than 1.5-fold. These results we infer that hMSCs underwent osteogenesis 
under laminar fluid shear stress exposure. This result was concordant with previous findings 
showing oscillatory fluid flow leading to increase in Runx2 expression in hMSCs[28] or 






Figure 3.5. Post fluid shear stress increase in late osteogenic markers. A. Shear stress directed increase 
in Osteopontin (OPN) and Osteocalcin (OCN) expression. B and C. Osteopontin and Osteocalcin 
showed increase both at protein and genetic levels. Number of cells counted = 80 in 3 independent 
experiments. Protein expression was normalised over the cell spreading area. mRNA expression was 
normalised over GAPDH expression of the cells. p>0.5 
 
For further validation of shear stress mediated-ostoegenesis of hMSCs, they were 
immunostained with late markers, Osteopontin (OPN) and Osteocalcin (OCN) expression. 
Fig.3.5A shows the images of the immunostained cells from static and fluid shear stress 
experienced cells and fig.3.5B shows ratio between the protein expression in flow and static 
cells. There was 2.4-fold increase in Osteopontin expression and 3.6-fold increase in 
Osteocalcin expression. mRNA expression of the two proteins also demonstrated 3.4-fold and 
3.1-fold increase in the activity of SPP1 (OPN gene) and BGLAP (OCN gene). The cells are 
considered to be expressing osteogenic markers since the expression of the markers is more 
than 1.5-fold. This suggests that the differentiation of hMSCs reached the late stages within 
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48 hours of shear stress exposure. Thus, fluid shear stress application not only differentiates 
the cells but also makes the process of differentiation faster than biochemical phenomenon, 
where OPN or OCN expression is observed only after 3-4 days [164]. Fluid shear stress has 
earlier also been demonstrated to accelerate the process of cardiovascular differentiation of 
embryonic stem cells by Illi et al [70].  
To confirm terminal differentiation of cells experiencing 48 hours of shear stress, hMSCs 
were maintained in osteogenic differentiation medium for 5 days in static condition post 
shear stress exposure. On day 5, extracellular calcium deposition by the cells was stained by 
ARS. Figure 3.6 shows the images of the channels post ARS staining. As can be seen, cells 
that underwent shear stress in the first 48 hours have more calcium deposition than the cells 
in static conditions thus indicating that the decision of terminal differentiation under FSS was 
taken as early as 48 hours of the flow. This hints that the cells experiencing fluid shear stress 
continue on the path of differentiation even after the fluid flow application is stopped.  
Figure 3.6. Shear stress mediated terminal differentiation of hMSCs. ARS staining suggests that after 
exposing hMSCs to fluid shear stress for 2 days and maintaining them in osteogenic differentiation 
medium for 5 days, extracellular calcium was deposited around the cells. 
 
Hence, under fluid shear stress, hMSCs followed osteogenic lineage and once the fate was 
decided, cells followed the path linearly. The observed results suggest that the decision by 
hMSCs to undergo osteogenesis under fluid shear stress is taken at very early stages of the 





force application. This observation helped in establishing a setup to direct shear stress 
modulated differentiation of hMSCs.  
3.4.2. Growth medium vs. Osteogenic differentiation medium 
Next, the fate decision of hMSCs upon fluid shears stress exposure using growth medium and 
differentiation medium was compared. Fig. 3.7A suggests that hMSCs underwent 
osteogenesis in both growth and differentiation (osteogenic induction) medium. However, the 
percentage of hMSCs undergoing osteogenesis under osteogenic induction medium was 
37.5% higher than the cells in growth medium. Only ~15% cells underwent differentiation in 
growth medium. This enhancement in osteogenesis observed in the presence of 
differentiation medium could be attributed to the significance of growth factors in the 
differentiation process. Availability of growth factors essential for osteogenesis in 
differentiation medium augments the paracrine effect [205–208], hence leading to increase in 
total number of cells undergoing differentiation. It was also understood that even though 
physical cue alone is enough for cells to determine their fate, addition of chemical cues 








Figure 3.7. Differentiation of hMSCs under fluid flow application.A. Increased differentiation using 
osteogenic differentiation (DM) medium for shear stress application. B. Expression of osteogenic 
markers under fluid shear stress increases by 48 hours and saturates after that, while the ones treated 
with chemical induction (Chem Ind) medium did not show any significant change in the prtein 
expression. Number of cells counted = 90 in 4 independent experiments. p <0.01. 
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As seen in fig 3.7B, the expression of osteogenic markers increased considerably after 48 
hours of fluid flow application. The expression levels plateaued after that. This suggests that 
the threshold of the expression of osteogenic markers was reached within 48 hours of fluid 
shear stress exposure. This is also supported by the results in previous section, where the cells 
kept in static condition after 48 hours of fluid flow application exhibited considerable amount 
of calcium deposition. Hence, for further experiments, the cells were analysed within 48 
hours of fluid flow exposure.  
3.4.3. Effect of different extracellular matrix protein (ECM) on differentiation 
As seen in previous sections of the chapter, fluid shear stress led to osteogenesis in hMSCs 
seeded on fibronectin. To investigate the lineage specification followed by cells on other 
ECM proteins, cells were seeded on collagen I and laminin. After 48 hours of shear stress 
exposure, cells were immunostained for Runx2 and OPN. Fig 3.8A shows expressions of 
markers in cells in static and flow conditions on the three ECM proteins. Images suggest that, 
post shear stress exposure, cells on fibronectin and collagen I expressed higher level of 
Runx2 and Osteopontin than the cells in static condition. However, the cells on laminin did 
not show any expression of the markers. Fig.3.8B demonstrates that the increase in Runx2 
expression was 3.1- and 2.7-fold and the increase in Osteopontin expression was 2.5- and 2.4-
fold than the static cells seeded on fibronectin and collagen I, respectively, while the 
expression of Runx2 showed only 1.2-fold increase and the expression of Osteopontin 
showed on 0.9-folds increase in cells seeded on laminin. The protein expression result from 
immunostaining was substantiated by measuring total mRNA concentrations of the two 
proteins in the cells seeded on different ECM proteins. As like protein expression, genetic 
expressions of the markers also showed similar pattern. Graph 3.8C shows that after shear 
stress exposure, 2.8- and 2.4-fold increase in RUNX2 expression and 3.4-fold and 2.4-fold 
increase in SPP1 expression in cells seeded on fibronectin and collagen I respectively. 





However, there was only 1.1- and 1-fold change in Runx2 and Osteopontin expression in 
cells seeded on laminin. Thus, hMSCs seeded on fibronectin and collagen I follow 












Figure 3.8. ECM regulated shear stress differentiation. A. Early (Runx2) and late (Osteopontin) 
osteogenic markers expressed on fibronectin, collagen I and not on laminin, after shear stress 
exposure. B. Protein quantification showed increase in the markers. C. mRNA expression of the 
markers increased in cells on fibronectin and collagen I. Number of cells counted = 90 in 3 
independent experiments. *p <0.01, **p<0.05. mRNA expression was normalised over GAPDH 
expression of the cells. 
 
Upon differentiation lineage confirmation, hMSCs seeded on different ECM proteins were 
immunostained for multipotency markers, CD90 and CD105 after fluid flow exposure. As 
can be seen in Fig. 3.9A, fluid shear stress led to decrease in expression of multipotency 
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markers in cells seeded on fibronectin and collagen I. Fig. 3.9B suggests that expressions of 
CD90 and CD105 reduced by 0.8- and 0.75-folds, respectively, on fibronectin. On collagen I 
also, expressions of CD90 and CD105 showed reduction by 0.78- and 0.69-folds, 
respectively.  However, there was no significant change in multipotency marker expression in 
cells seeded on laminin. The immunostaining results were supported by qPCR of the 
multipotent gene expressions. Fig. 3.9B shows that the expressions of the THY1 and ENG 
also reduced on both fibronectin and collagen I while it remained same as that of static 










Figure 3.9. Multipotency markers expressions in hMSCs seeded on ECM after shear stress exposure. 
A. Multipotency markers, CD90 and CD105 reduced on fibronectin and collagen. Their expression 
remained same on Laminin. B and C. Fold change in protein and mRNA expression of the 
multipotency markers. Number of cells counted = 95 in 4 independent experiments. *p <0.01, 









Hence, the cells seeded on fibronectin and collagen I underwent osteogenesis, while the cells 
seeded on laminin remained multipotent, even after shear stress exposure. Osteogenesis 
















Figure 3.10. Spreading area of hMSCs on ECM proteins. A Phalloidin stained cells spread more on 
fibronectin and collagen I than Laminin B. Histograms of cells spreading area on ECM proteins. 
Number of cells counted = 200 in 3 independent experiments. (Scale: 20µm). 
 
This variation in differentiation pattern of hMSCs on different ECM proteins could be 
attributed to the spreading area of the cells on different ECM proteins. To support the 









calculated. Fig. 3.10 shows the histogram of the spreading area distribution of the cells on 
fibronectin, collagen I and laminin. As can be seen, hMSCs have a wider range of spreading 
on fibronectin and collagen I, but the cells on laminin have smaller spreading area. Upon 
application of fluid flow on these cells, they did not exhibit considerable change in their area 
indicating that ECM directed morphological characteristics are preferred by the hMSCs. 
Previous studies have shown that spreading area of the cells helps in predetermining its 
lineage [16, 86, 133]. The varied spreading area of the hMSCs could be attributed to the 
differential integrin expression in the hMSCs on different ECM proteins, which would be 
allowing a preferential binding pattern of the cells to fibronectin/collagen leading to cell 
spreading. The spreading area distribution of the hMSCs on each of the ECM proteins 
remained unchanged after shear stress application. Thus, the difference in fate chosen by 
hMSCs seeded on different ECM protein could be predetermined due to their acquired 
spreading area and fluid shear stress may be accelerating the process of fate determination on 
fibronectin and collagen I. 
3.4.4. Effect of shear stress magnitude on differentiation 
Fluid shear stress applied on hMSCs was varied by changing the flow rate of the fluid. Fig. 
3.11 plots the ratio of Runx2, OPN, FLK-1 and SMA expressions between the cells 
undergoing shear stress and the cells in static condition. It is evident from the graph that the 
osteogenesis peaked between 1-1.5 Pa shear stresses. Below 1 Pa and above 1.5 Pa shear 
stresses, hMSCs showed low expression of the osteogenesis markers. Endothelial marker 
(FLK-1) and smooth muscle marker (SMA) did not show much alteration in their expression 
upon shear stress exposure. Low osteogeneic marker expression at shear stresses lower than 1 
Pa could be attributed to less physical strain generated on the cells. 





And, diminished differentiation at higher shear stresses could be because of limited receptor-
ligand interactions. High fluid flow rates might cause unavailability of paracrine and other 
growth factors (present in flowing medium) and inhibit cell differentiation. Previous studies 
have shown that paracrine effect of growth factors is important in influencing the lineage 
specific genes while hMSCs differentiation [10, 11, 13–16]. 
Figure 3.11. Fold change in Runx2, OPN, FLK-1 and SMA expressions plotted over different fluid 
flow rates. p<0.01 
 
3.5. Conclusions 
hMSCs, being an adult multipotent stem cells with the ability to differentiate into varied 
lineages, is an attractive candidate for stem cells based therapies[5]. However, increasing 
evidences suggest that stem cell based therapies require a deeper understanding of the 
response of stem cells towards the surrounding environment which is a combination of both 
biochemical and physical components. For developing better therapeutics, it is rather 
important to carefully segregate the components present in the stem cell niche and understand 
their effect on cells. One such effort is to understand the impact of physical constituents of 
the stem environment on the process of their survival, self-renewal and fate determination.  





To extend it further, in this chapter of the thesis we wanted to understand the role of 
mechanical stress acting on the entire cell. Thus, we have emphasized on the differentiation 
of hMSCs mediated by a physical signal, fluid shear stress. Here, first, we have highlighted 
the optimum conditions required for the differentiation of hMSCs under fluid flow.  
Immunostaining and qPCR of cells with multipotency and osteogenic markers demonstrated 
that stem cells follow osteogenic lineage upon activation by fluid shear stress. This result is 
similar to the study by Arnsdorf et al which emphasises on the commitment of hMSCs to 
osteogenic lineage after fluid shear stress application using osteogenic induction medium 
[28]. The decision to undergo terminal differentiation was taken within 48 hours of shear 
stress exposure and hMSCs underwent osteogenesis even after the fluid flow application was 
stopped. Hence, once the signalling pathways leading to osteogenesis in hMSCs are 
activated, even after the removal of the fluid flow application, the signalling cascade stays 
active, eventually leading to terminal differentiation of hMSCs. 
We also observed that the percentage of cells undergoing differentiation increased 37.5% 
upon changing the flowing medium from growth medium to osteogenic induction medium. 
These cells were found to show maximum differentiation in a range of 1-1.5 Pa, which lay 
within the physiological shear rates faced by hMSCs[20].  
It was also demonstrated that the fate chosen by hMSC when exposed to fluid shear stress 
varied with the ECM protein on which it was seeded. On collagen I and fibronectin, fluid 
shear stress directed osteogenesis of hMSCs while on laminin, they remained multipotent. 
This difference in cell response could be due to the difference in observed spreading area of 
the cells and the possible preferential interaction of each ECM proteins with certain integrins. 
 
 













Figure 3.12. hMSCs undergo osteogeensis when exposed to FSS. A. FSS mediated osteogenesis is 
regulated by a range of FSS (1-1.5 Pa) and underlying ECM (fibronectin and collagen I). B. 
Multipotency of hMSCs is retained on laminin matrix, even in on FSS application.   
 
In conclusion, we found that adult stem cells had specific response to shear stress application. 
Osteogenesis, in 1-1.5 Pa, suggests that below the given range enough mechanical force is 
not generated and above this range growth factors might not be available to aid in 
differentiation by paracrine effect (Fig. 3.12). This indicates that fluid shear stress mediated 
hMSC differentiation is a combinatorial effect of both biochemical and mechanical 
microenvironment of the stem cells.  
Further studies can be performed to understand the combinatorial effect of the two factors 
(biochemical and mechanical factors) in detail. Varying each of the factors while controlling 
the other will help in revealing exact mechanism involved in the process. Also, it will provide 
more information to create better platforms for tissue engineering applications for improved 
cell based therapies.  
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It would also be relevant to understand the mechanism underlying laminin and hMSC 
interaction. This will help in answering the important question about retaining the 








4. Role of cell contractility in shear stress-mediated hMSC fate 
4.1. Preview 
This chapter elucidates the significance of contractility in the process of shear stress 
facilitated hMSC differentiation. First we introduce the importance of contractility in lineage 
specification and then how the gap in the current knowledge can be filled. The methods and 
materials involved will next be presented. We will then investigate how the shape, stiffness, 
contractility and focal adhesions of hMSCs change when fluid shear stress is applied. We will 
attempt to identify the variation in contractile behavior of cells depending on their alignment. 
Lastly, we will demonstrate how extracellular matrix controls the contractility of hMSCs. 
 
4.2. Introduction  
In stem cell biology, recent studies have broadened the scope of knowledge from 
understanding the role of soluble factors [213, 214]
 
to comprehending the role of mechanical 
factors in the process of differentiation. With new developments in the field, the role of 
physical characteristics of cell microenvironment (for example, shape constraint [133] or 
substrate elasticity [16]) in directing the hMSC differentiation has been greatly emphasized. 
These cells, being downstream in cell-lineage determinations, have reduced self-renewal and 
differentiation capacities. However, the understanding of the basic mechanisms through 
which hMSCs respond to mechanical forces is pivotal in gaining insight into the process of 
differentiation and organism development. 
hMSCs show increased proliferation and expression of smooth-muscle-cell markers under 
cyclic uniaxial stretching of the cells [22]. Global forces like shear stresses up-regulate the 
signalling cascades like MAPK [209] pathway and intercellular calcium signalling [25, 85, 




91]. At the same time, fluid shear stress also causes the differentiation of the stem cells into 
both vascular endothelial cells and osteoprogenitor cells [78]. The shape conformed by the 
cells has also been found to have a major effect on the activation of apoptotic pathways and 
also on their decision to follow osteogenic, adipogenic, chondrogenic or myogenic lineage 
[86, 133, 215]. 
In the previous chapter, we found that hMSCs respond to shear stress by undergoing 
osteogenic differentiation. Even though the presence of supplementary induction factors 
accelerates the process, the process is initiated regardless of their involvement. Thus, physical 
factors can solely activate the process of differentiation in hMSCs. However, the detailed 
mechanism of activation of hMSCs towards following the osteogenic lineage is still not very 
well understood.  
In light of the excellent progress in studies on the effect of the mechanical constraints on the 
cells, it is now important to understand the role of the fluid flow in regulating the fate of 
hMSCs. Previous studies have shown that fluid shear stress has multiple effects on hMSCs 
[82]. Response of hMSCs to fluid shear stress has been quantified by measuring an increase 
in the concentration of Ca
2+
 [25, 85, 87] and remodelling of actin cytoskeleton has been 
reported in hMSCs during osteogenic differentiation [210]. Several molecules like Focal 
adhesion kinase (FAK), MAPK and Rho GTPases [28] are significant players in  
mechanotransduction of applied shear stress. The mechanical stress activates ERK1/2 also, 
which can influence the expression and activation of transcription factors, such Runx2 and 
AP-1 [88, 216].  
Taken together, existing data suggests that hMSCs differentiate when subjected to fluid shear 
stresses. Changes in molecules mediating intracellular contractility are also evident. 




However, the relationship between the shear stress mediated intracellular contractility, and 
lineage specification still remains elusive.  
In this chapter, we will elucidate the link between shear stress, cell contractility and stem cell 
differentiation. The effect of cell orientation and ECM on cellular responses when subjected 
to shear stress will also be discussed. 
 
4.3. Experimental methods  
 
4.3.1. Coating of microfluidic channels with ECM proteins 
Microfluidic channels were coated with different ECM proteins (fibronectin, collagen I and 
laminin) similarly as mentioned in section 3.3.3. 
4.3.2. Cell Culture and Fluid Flow conditions 
Human MSCs (Lonza Inc.) were maintained in hMSC growth medium (Lonza Inc.) 
supplemented with 1% penicillin/streptomycin (Invitrogen). Passages 1-5 of cells were used 
in the experiments. 1000 cells/cm
2 
were seeded onto the microfluidic channels. Low seeding 
density of cells was used to characterise single cell response to fluid shear stress. 
hfMSCs ( human fetal Mesenchymal stem cells) were obtained from bone marrow of fetal 
human donors and extracted using established centrifugation and plastic-adherence 








4.3.3. Live cell imaging 
Live cell imaging was performed on a microscope equipped with temperature, humidity and 
CO2 control (Olympus Live EZ Widefield System). Phase contrast images were acquired 
every 10 minutes using a 20x objective, typically, over a period of 12 to 24 hours. 
4.3.4. Quantification of cell shape and area 
Cell boundary was traced manually. ImageJ was used to measure perimeter (P) and area (A) 
of the cell. Cell Shape Index (CSI) was calculated to determine the shape of the cells. It is the 
measure of circularity of the cell (1 = circle, 0 = line), where,     
   
  
. 
4.3.5.  Quantification of height of cells 
Actin microfilaments were stained by Phalloidin (Invitrogen). Z-stacks of XY-planes of the 
stained cells were obtained in Nikon Confocal A1R system. ZY-plane was obtained by 
stitching the planes and interpolating them. A line was drawn across the ZY-plane of the cell 
and intensity was measured using ImageJ. Width of increased intensity was quantified and 
plotted as height of the cell.  
4.3.6. Cell stiffness measurements and quantification 
hMSCs were subjected to constant fluid flow for 6hr, 12hr, 24hr and 48 hr. Channels were 
dismounted from the flow circuit, removed and glass coverslips were placed on the 
temperature controlled stage mounted on an atomic force microscope (AFM; Nanowizard II 
BioAFM, JPK instruments AG). Nanoindentation was performed on the cortical cytoskeleton 
region of cells (away from nucleus) by force mapping technique over a grid of 8x8 using a 
polystyrene bead (∼4.5 μm in diameter) fixed to the end of a silicon nitride (SiN) cantilever 




(k = 0.03 N m−1, Novascan Technologies)) at a force of 2.5 nN at 1 Hz. Obtained indentation 
curves were fitted with a Hertz model using JPK Data Processing Software (JPK instruments 
AG) to determine the Elastic modulus. 
4.3.7. Immunocytochemistry, confocal imaging and quantification 
Cells were immunostained, imaged and their protein expression intensities were quantified 
using the same protocol as mentioned in section 3.3.5.  
Primary antibodies used were Anti-Non-Muscle Myosin IIA (Sigma-Aldrich) at 1:500, Anti-
RhoA (SantaCruz Biotechnology, Inc.) at 1:200, Anti-Osteopontin (SantaCruz 
Biotechnology, Inc.) at 1:200, Anti-RunX2 (SantaCruz Biotechnology, Inc.) at 1:200, Anti-
phospho-ERK (1/2)(Cell Signaling Technology; Extracellular signal-regulated kinase ) at 
1:500 and Anti-Paxillin (Cell Signaling Technology) at 1:500. Alexa Flour
®
 (Invitrogen) 
secondary antibodies were used. 
Graphs were plotted as mentioned in section 3.3.5. 
4.3.8. mRNA expression profiles 
Total RNA was isolated from hMSCs, after fluid shear stress exposure, with RNeasy Mini 
Kit (Qiagen). It was then was reverse-transcribed with iScript
TM
 Reverse Transcription 





Supermix (Bio-Rad) on a Bio-Rad CFX96
TM
 Real-Time PCR Systems. Primers and probe 
sets for MYH2 (Non-muscle myosin heavy chain; NM_001256012.1), RHOA (RhoA; 
NM_001664.2), RUNX2 (runt-related transcription factor 2, NC_000006.12), SPP1 
(Osteopontin; NC_000004.12), and GAPDH (GAPDH; NC_000012.12) were purchased from 
AIT Biotech. qPCR was performed with following conditions: 95°C for 30 sec, followed by 




40 cycles at 95 °C for 3 sec and 58 °C for 4 sec. ΔCt was then calculated with respect to the 
loading control (GAPDH) for each sample; ΔCt of gene of interest was normalised to that of 
the control (static condition at the same time point) to obtain ΔΔCt. The fold change in the 
expression of the gene was calculated using the formula 2
−ΔΔCt
 [201]. 
Table 4.1. List of primer sequences used for qPCR 
Gene Forward Primer Sequence Reverse Primer Sequence 
GAPDH CTTTGTCAAGCTCATTTCCTGG TCTTCCTCTTGTGCTCTTGC 
MYH2 CAGACCAAAGAACAGGCAGA TCGCATCAATAAAGCTCTGG 
RHOA GGGAGCTAGCCAAGATGAAG TGGAGTGTTCAGCAAAGACC 
RUNX2 TTCACCTTGACCATAACCGTC GGCGGTCAGAGAACAAACTAG 
SPP1 AGGCTGATTCTGGAAGTTCTG CTTACTTGGAAGGGTCTGTGG 
4.3.9. Inhibitor drug treatments 
To perform drug inhibitor experiments, hMSCs were treated prior to application of fluid flow 
with 25µM Blebbistatin (Myosin II inhibitor; Sigma-Aldrich) for 30 mins, 5µM Y-27632 
(Rho-associated Kinase inhibitor; Sigma-Aldrich) for 10 mins, 100 nM Cytochalasin D 
(Actin inhibitor; Sigma-Aldrich) for 30 mins and 5 µM Latrunculin A (disrupts Actin; Sigma-
Aldrich) for 1 hour. After drug treatment, cells were exposed to fluid flow using osteogenic 
induction medium supplemented with drug.  Graphs were plotted as a ratio of expression of 
the cells facing fluid flow to that of expression of the static cells.  
4.3.10. Microcontact printing  
Micro-contact printing was performed to attain protein micro-patterns on PDMS coated glass 
surfaces used in experiments in section 4.3.4.  This procedure includes preparation of PDMS 
stamps from pre-silanised silicon wafers containing desired features, inking of PDMS stamps, 




stamping of protein micropatterns on to PDMS coated glass and the passivation of the non-
inked areas of the substrate.  
PDMS coated glass coverslips were prepared by spin coating 1:5 (curing agent: base) ratio of 
PDMS using a spincoater (Model WS-400BZ-6NPP/LITE from Laurell Technologies 
Corporation). Spin coated PDMS was cured at 80°C for 2 hours. 
1:10 ratio of curer to base was used for preparing PDMS stamps. They were homegenously 
mixed and then poured into pre-silanized silicon wafer (Refer to section 3.3.2 for Silanisation 
Protocol). PDMS covered wafers were then degassed to remove all the trapped air bubbles. 
They were then cured at 80°C for 2 hours. Cured PDMS stamps were cut apart and peeled 
off. PDMS stamps with desired features were treated with air plasma in plasma cleaner 
(Model PDC-002, Harrick Scientific Corp) for 2 minutes. Stamps were then coated with 
20μg/ml fibronectin solution, which was a mixture of Cy-5 conjugated (Refer to appendix A1 
for detailed protocol for conjugating Cy-5 dye to fibronectin) and unlabeled fibronectin, 
diluted in deionized water in 1:1 ratio. Cy-5 dye conjugated fibronectin helps in better 
visualization of protein micro-pattern after transfer. PDMS stamps were then incubated for 20 
mins with the protein coating to allow adsorption of protein onto the PDMS surface. Excess 
protein left after the incubation was absorbed away from one corner of the stamp using a 
tissue paper. PDMS stamp was then inverted and placed on the PDMS coated glass cover 
slip, thus allowing the transfer of micro-patterns. Post-stamping, samples were checked using 
a fluorescent microscope to confirm the proper transfer of fibronectin patterns (Fig. 4.1). Rest 
of the surface was then made passive to cell attachment using 2mg/ml Pluronic F-127 for 2 
hours. Pluronic F-127 was then removed by three washes of 1X PBS, each wash for 5 mins. 
Cells were seeded immediately after micro-pattern stamping. 
 









Figure 4.1. Micropatterning on PDMS coated glass coverslip.A.Protocol. B. Stamped fibronectin 
lines. Scale: 100µm 
4.3.11. Focal adhesion area measurement 
Individual focal adhesions were traced manually using ImageJ, counted and their area was 
measured and plotted. 
 
4.4. Results and Discussion 






Figure 4.2. Shear stress mediated-cell area change over time. A. hMSC area remains steady B. hfMSC 
area reduces and then becomes steady. 60 cells were imaged at in 3 independent experiments at a 
frame rate of 1 frame/minute. 
 
hMSCs showed a considerable amount of change in their shape when they are exposed to 
fluid flow. Figure 4.2 shows the change in projected cell area over time when cells were 
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facing fluid shear stress. As can be seen in fig.4.2A, cell area kept fluctuating over time, but 
remained constant overall. There was an initial contraction in the cell area. However, 
subsequently cells regained the original area. This cellular behaviour was in accordance with 
the response of the rat fetal mesenchymal stem cells (rfMSCs) in the presence of fluid flow as 
seen by Zheng et al. [212]. rfMSCs contracted and there was reduction in the cell area and 
then they regained their size slowly. Fig.4.2B shows that human fMSCs demonstrated similar 
behaviour as that of rfMSCs. Similarity in the morphological response of different stem cells 
could be attributed to the stage of stemness of the cells. Multipotent cells, being more fluidic 
[219, 220], could respond instantaneously to the applied external force. This is also similar to 
the retraction of ESCs on stimulation by local vibrations using magnetic beads as seen by 









Figure 4.3. Fluid flow mediated hMSC shape change. A. Cells in static condition did not show change 
in the shape. Cells facing shear stress became more elongated. B. CSI did not change significantly in 
static cells while reduced considerably in cells experiencing fluid flow. 60 cells were analysed in 3 
independent experiments to determine the shape change of hMSCs. The reduction in CSI is 
statistically significant with respect to t=0. (p<0.05) 
Even though the cell area remained constant through the process, the shape of the cell 
underwent considerable changes. Figure 4.3A depicts a cell at different time points of facing 
the shear stress. Cells in static condition did not show much change in their shape even after 3 
hours. However, when hMSCs were exposed to fluid shear stress, they changed their shape 
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from lesser contractile shape (square) to a more contractile shape (elongated). Graph in 
fig.4.3B suggests that CSI of cells in static condition remained steady whereas when these 
cells were subjected to shear stress their CSI reduced, indicating that the cells were becoming 
elongated. However, the change occurred very slowly.  
Although change in the shape of the cell is very slow, the initial change in alignment of the 
lamellipodia of the cell along the fluid flow direction can be clearly seen. The kymographs in 
fig.4.4 show slow changes in the upstream and the downstream side of lamellipodia of the 
cell. Retraction of lamellipodia in the upstream side and increased spreading in the 
downstream side, within 5 mins of flow induction, indicate the beginning of the process of 
cell alignment along the flow direction. 
Figure 4.4. Kymographs of upstream and downstream lamellipodia. Upstream lamellipodium spread 
with time and the downstream lamellipodia retracted.  
A considerable change in the height of the cells was also observed. Heights of individual cells 
were measured at different time points (0hr, 6hr, 12hr, 24hr and 48hr) from the YZ-view of 
the z-stack of phalloidin stained cells. Graph in fig.4.5 shows that height of hMSCs reduced 
with the fluid shear stress exposure. The reduction in height was 25% from 8.2 µm to 6.1 µm. 




Similar results have been seen by Galbraith et al in endothelial cell monolayer as a result of 
spatial reorganization of the endothelial cell cytoskeleton [58]. This flattening of cells could 
be a result of the pressure applied on the cells by the fluid flow. The shear stress applied on 
the apical region of the cell could lead to alterations in the cellular cytoskeleton leading to the 
decrease in cell height. This could also be related to the change in the shape that the cell is 
undergoing. 
Figure 4.5. Height of the cell upon shear stress exposure. Static cell height remained steady and 
unchanged. Height reduction was observed in cells undergoing shear stress. 50 cells were analysed 3 
independent experiments to measure cell height. The reduction is cell height is statistically significant 
with respect to the cell at t=0. (p<0.05) 
4.4.2. Change in cell stiffness with shear stress exposure 
Cell elastic moduli, as reported previously, varies with cell type such as, 1.662 0.2 kPa for 
3T3 fibroblasts [213], 1.5–5.5 kPa for endothelial cells [216], 1.86 0.3 kPa for fibroblasts 
[213], 1–2 kPa for osteoblasts [118, 222], and 0.3–30 kPa for bone marrow stromal cells 
[118,  223]. Thus to understand long term changes in internal cytoskeletal properties of 
hMSCs, post shear stress exposure, the elastic modulus of the cells was measured. Graph in 
fig.4.6B plots the distribution of the elastic modulus of cells in static condition and cells 
undergoing fluid shear stress exposure at different time points (6 hr, 12 hr, 24 hr and 48 hr). 
As can be seen, with time, the elastic modulus of hMSCs reduced from 3.5 1.1 kPa to 1.8 
0.4 kPa upon 48 hours of fluid flow. Thus, the cells became softer upon shear stress exposure 




as represented by the reduction in the mean value of the elastic modulus distribution of the 
cells. The softening of the cells could be because of the change in the actin cytoskeletal 
structure of the cells upon shear stress exposure. The images in fig.4.6A suggest that hMSCs 
in static condition had long and bundled stress fibres, most of which ran from one focal 
adhesion to another. However, the cells, after fluid shear stress exposure, had cross-linked 
actin cytoskeleton and shorter stress fibres. Study by Titushkin et al. demonstrated similar 
changes in the cytoskeleton arrangement in hMSCs undergoing osteogenesis. Chemically 
induced differentiation of adult mesenchymal stem cells changed the stronger and longer 
stress fibres of MSCs to cross-linked actin cytoskeleton of osteocytes [109]. In our study, the 
cytoskeletal changes and cellular elastic modulus in cells before and after shear stress 
exposure is comparable to undifferentiated MSCs and osteocytes, respectively [118, 222, 
223]. This alteration in cellular cytoskeleton could be an indication of the lineage chosen by 









Figure 4.6. Distribution of elastic modulus of hMSCs upon facing fluid flow. A. Phalloidin stained 
confocal images of hMSCs to visualise actin. B. Reduction in cell elasticity upon shear stress 
























Figure 4.7. Change in hMSC contractility after being subjected to fluid flow. A. Confocal images of 
hMSCs immunostained for NMM II A at different time points of fluid flow. B and C. Cells showed 
increase in NMM II A genetic and protein expressions. D. Confocal images of hMSCs immunostained 
for RhoA at different time points of fluid flow. E and F. Cells showed augmented genetic and protein 
expression of RhoA. 75 cells were analysed in 4 independent experiments. The direction of arrow 
denoted the fluid flow direction. mRNA expression was normalised over GAPDH expression of the 









Cellular contractility was estimated by measuring the expressions of total Non-muscle 
Myosin II A (NMM II A) and RhoA. Graph in fig. 4.7 depicts the ratios of NMM II A and 
RhoA expressions at different time-points (6 hr, 12 hr, 24 hr and 48hr) between the static 
cells and the fluid shear stress undergoing cells. As can be seen in the graph 4.7B, the 
expression of NMM II A increased 2.7-fold, 3-fold, 3.4-fold and 3.5-fold at 6hr, 12hr, 24hr 
and 48hr respectively upon shear stress exposure. RhoA expression as seen in graph 4.7D 
also augmented by 2.2-, 2.4-, 2.8-, 2.9-fold at 6hr, 12hr, 24hr and 48hr respectively.  To 
substantiate the results, mRNA expression of the cells was also measured. The fold changes 
in the mRNA expressions of the two contractile proteins also showed increasing trend. The 
increases in  NMM II A, motor protein resulting in the actomyosin contractile behavior, and 
RhoA, an activator of NMM II A expressions at both protein and genetic levels showed an 
increase in the contractility of the cells upon fluid shear stress exposure upon time. 








Figure 4.8. Inhibition of shear stress mediated osteogenic differentiation by actomyosin disruption.   
A. Fold change in Runx2 expression in cells treated with pharmacological drugs. B. Fold change in 
Osteopontin expression in cells treated with pharmacological drugs. 90 cells were analysed in 3 
independent experiments. 75 (Runx2) and 90 (OPN) cells were analysed in 3 independent 
experiments. p <0.001. 
Reduction in cell stiffness and increment in contractile nature of cell could be explained by 
the effect and measurement of the two characteristics at different cell regions. Cell stiffness is 
measured in the apical region and the contractile proteins might be active only in the basal 
A B 




regions. Staining for the active forms of NMM II A and RhoA will give a better 
understanding of such contradicting behavior of cells. 
To realize the role of contractility in the decision of fluid shear stress mediated fate, cells 
were treated with actomyosin contractility inhibiting drugs while undergoing fluid shear 
stress. Blebbistatin (Myosin II inhibitor; Bbstn), Y-27632 (ROCK inhibitor), ML7 (Myosin 
Light Chain inhibitor), Cyytochalasin D (Actin inhibitor; Cyt D) and Latrunculin A (Actin 
inhibitor; Lat A) were used to impair the actomyosin contractility. Fig.4.8 shows the 
expression of Runx2 (early osteogenesis marker) and OPN (late osteogenesis marker) upon 
shear stress exposure, in the presence of actomyosin inhibiting drugs. As can be seen, OPN 
expression in the cells, facing shear stress under actomyosin drug treatment, remained steady 
as opposed to the cells in untreated condition. Thus, even upon fluid shear stress application, 
hMSCs do not differentiate when actomyosin contractility is impaired in cells. This suggests 
that actomyosin contractility is crucial for fluid shear stress-mediated osteogenesis of hMSCs. 
Importance of cellular contractility has also been reported previously in studies from 
McBeath et al. and Engler et al., which have realized cellular contractility to be pivotal in cell 
spreading- and substrate stiffness-mediated differentiation of hMSCs, respectively [16, 133]. 
Hence, hMSC contractility plays a pivotal role in helping the physical components of the 
stem cell niche to determine the fate of the cell.  
4.4.4. Focal adhesion changes under fluid flow 
Alterations in focal adhesions were also studied at different time points (0hr, 6hr, 12hr, 24hr 
and 48hr) of fluid shear stress exposure. Paxillin (a focal adhesion protein) was 
immunostained to visualize the focal adhesions. Fig.4.9 shows that focal adhesion area 
increased 1.6-times to 2.4-times after 6hr and 48hr of fluid shear stress exposure. Rose plots 
of focal adhesion alignment relative to fluid flow direction indicated that focal adhesions 




were haphazardly arranged in static cells whereas they get aligned along the flow direction 
when cells were subjected to fluid flow. FAK activation in endothelial cells by fluid shear 
stress has been seen as early as 1997 by Li et al. [219]. They are also believed to play pivotal 
role in mechanotransduction of forces generated by fluid flow in osteoblasts [103]. It is likely 
that the focal adhesion proteins transduce fluid shear stresses into actomyosin rearrangement 
and lead to activation of signaling pathways directing osteogenesis specific-genes in hMSCs 
also. This also suggests the reinforcement of actomyosin contractility along the direction of 
flow and supports the premise that shear stress impinges on cellular contractility, by 
modulating cellular cytoskeleton and focal adhesions, to decide the lineage of the cell. 
 







Figure 4.9. Fluid flow directed focal adhesion changes. A and B. Focal adhesion area increased. 
Images in inset show the zoomed image of focal adhesions of each cell.  C. Focal adhesion aligned 
along the flow direction. 90 cells were analysed to calculate the fold change in focal adhesion area 
and the alignment of the focal adhesions in 4 independent experiments. The direction of arrow 










4.4.5. Effect of cell alignment on fluid shear stress mediated-differentiation 
hMSCs were allowed to be aligned either along or across the flow by micro-contact printing 
of 3µm wide and 200µm long lines each separated by 50µm. The dimensions were chosen to 
allow the alignment of the cells only along the length of the micropattern, which would help 
in controlling the cell alignment along or across the flow. Elongated thin lines of ECM 
micropatterns allow cells to align along their axis [220]. Cells aligned along and across the 
flow were then compared for change in actomyosin contractility as an effect of applied fluid 
shear stress. Measurement of total NMM II A and RhoA expressions at different time points 
(6 hr, 12 hr, 24 hr and 48 hr) in hMSCs aligned along and across the flow direction has been 
shown in fig.4.10 (A, B and C). As can be seen in the graphs (fig. 4.10B and C), genetic and 
protein expressions of NMM II A in cells aligned across the flow increased with time. 
However, remained unchanged in cells aligned along the flow, suggesting, alignment of the 
cell directs the fluid shear stress modulated alterations in intracellular contractility. 
As discussed in section 2.8.1, MAPK pathway, is one of the upstream pathways of NMM II 
A activity, is one of the activators of Runx2, an important transcription factor regulating the 
osteogenesis pathway. To understand the relevance of MAPK pathway in shear stress 
mediated osteogenesis, we evaluated the expression of phosphorylated ERK(1/2). Phospho-
ERK(1/2) quantification, at 48 hr post fluid flow exposure, was plotted in graph shown in 
fig.4.10E. As like NMM II A expression, images (fig.4.10D) and graph (fig.4.10E) depict 
that more ERK(1/2) was getting phosphorylated in cells aligned across the flow with time 
than the static cells as opposed to the cells aligned along the flow direction, which did not 
show much change in the phosphorylation.  
 
   





















Figure 4.10. Cell alignment affected the contractility changes in hMSCs. A,B and C. Genetic and 
protein expressions of NMM II A in cells aligned perpendicular or parallel to the flow direction. D 
and E. Activation of ERK(1/2) regulated by cell alignment relative to flow direction. Results were 
obtained from 3μm wide lines. 60 cells were analysed in 3 independent experiments. mRNA 
expression was normalised over GAPDH expression of the cells. p <0.01. 
This difference in the contractile protein expressions of hMSCs on fluid flow exposure based 
on its alignment could be attributed to the shear force faced by the actin stress fibres of the 
cells. As can be seen in images of fig.4.10A, hMSCs had NMM II A aligned along the length 
of the cells. These contractile proteins were arranged parallel to the cells when cells are 









are aligned across the flow. So, during the fluid flow applications, the actin microfilaments 
attached to NMM II A (a motor protein) that are perpendicular to the flow might be facing 
more deformation than the filaments which are parallel to the flow. Thus to prevent their 
breakage due to applied force, actomyosin cytoskeleton may be undergoing strengthening by 


















Figure 4.11. Shear stress controlled differentiation in aligned cells. A, B and C. Quantification of 
protein expression of osteogenic markers in perpendicular and parallel hMSCs. Osteogenic markers 
(Runx2 and OPN) expressions in perpendicular and parallel cells. D. Differentiation do not occur in 
the presence of actomyosin inhibitors. 75 cells were analysed in 3 independent experiments. mRNA 









After realizing the alteration in cellular contractility attributed to their alignment under fluid 
shear stress, cells were immunostained with osteogenic markers, OPN and Runx2. Graphs 
and images in fig.4.11 show the change in expression of the osteogenic markers in hMSCs on 
shear stress application at different alignments. Cells that were aligned across the flow 
direction showed higher expression of the markers post shear stress exposure than the static 
cells, while the cells aligned along the flow direction did not express the osteogenic markers 
post fluid flow exposure. This result is in accordance with the change in cellular contractility 
when they experience shear stress while remaining aligned in a certain direction. Also, the 
graph depicts that upon inhibition of actomyosin contractility, cells were negative for 
osteogenic marker, Osteopontin, in every alignment. This indicates that cellular contractility 
altered with variation in the direction of application of force and cell alignment and the 
increase in cell contractility is critical for fluid shear stress modulated osteogenesis. This 
increase in cell contractility might be activating the cell osteogenic differentiation pathways 
by impinging on the transcription factors relevant for the osteogenic genes. However, only 
30% cells were differentiating in such aligned conditions (fig. 4.12). This limited 
differentiation in the aligned cells could be because of limited contractility generated in the 
cells. Cells might need to attain optimum contractility in order to differentiate. 
   Figure 4.12. Higher percentage of cells differentiate while aligned perpendicular to the fluid flow 
direction than parallel to it. 200 cells were analysed in 3 independent experiments. p<0.01. 
























In chapter 3, we elucidated the difference in the differentiation pathways adopted by hMSCs 
when they are seeded on different ECM proteins: fibronectin, collagen I or laminin. We 
hypothesized that this differential response of cells is a result of variation in spreading area 






Figure 4.13. ECM protein mediated changes in NMM II A expressions upon fluid flow exposure. A 
and B. Contractility changes visualized and measured by NMM II A immunostaining and mRNA 
quantification in hMSCs when seeded on different ECM proteins and experienced shear stress.65 
cells were analysed in 3 independent experiments. mRNA expression was normalised over GAPDH 
expression of the cells. p <0.01 




been seen to affect the contractility of the cells [124]. Thus, to confirm a similar occurrence 
here, hMSCs, seeded on different ECM proteins, were subjected to fluid flow and then 
immunostained for NMM II A and Rho A. Fig.4.13 represents the expression of NMM II A 
at different time intervals (6hr, 12hr and 24hr) after shear stress exposure of cells seeded on 
fibronectin, collagen I and laminin. As can be seen, protein and mRNA expressions of NMM 
II A and MYH2, respectively in the cells seeded on fibronectin and collagen I increased with 
time of shear stress exposure while the expressions in the cells seeded on laminin remained 










As represented in fig.4.14, similar augmentation in RhoA genetic and protein expression 
were observed in hMSCs subjected to fluid flow for 12 hours on the three mentioned ECM 
proteins. This indicates that contractility of cells seeded on fibronectin and collagen I increase 
upon fluid shear stress exposure while that of cells seeded on laminin do not show any 
change. Thus, the hMSCs on fibronectin and collagen I are more spread and upon shear stress 
exposure, their contractility increases and eventually they undergo osteogenesis. In contrast, 





Figure 4.14. ECM protein mediated changes in RhoA expressions upon fluid flow exposure. Protein 
and genetic expression images and quantification of RhoA in hMSCs seeded on fibronectin, collagen 
I and laminin. 80 cells were analysed in 3 independent experiments. .mRNA expression was 
normalised over GAPDH expression of the cells. p <0.01 




does not increase and their multipotency is maintained. These results iterate the previous 
findings that contractility of the cell plays a pivotal role in fluid shear stress mediated 
differentiation thus suggesting that stem cell contractility directs the fate chosen by the cell.  
4.5. Conclusions 
Differentiation response of cells is directed by both externally-applied and cell-generate 
physical forces. Several compelling evidences have emerged in past one decade suggesting a 
strong interplay of the two forces in mesenchymal stem cells. Preliminary studies suggest that 
Rho/ROCK signaling [124] and NMM II isoforms [16] generated contractility controls shape 
and spreading mediated- and substrate elasticity mediated-lineage specification of 
mesenchymal stem cells, respectively, however a specific relationship between contractility 
and externally applied force remains unexplored. As like internal cellular properties (cell 
shape) and ECM properties (substrate elasticity), applied external forces, such as, fluid shear 
stresses induce molecular modifications, especially cytoskeletal protein reorganizations 
[107]. In this chapter, the shear stress mediated changes in the contractility of the hMSCs was 
studied. Under fluid flow, hMSCs underwent early morphological changes, including change 
cell shape and cell alignment. Elastic modulus of hMSCs also reduced from 3.5 1.1 kPa to 
1.8 0.4 kPa after shear stress application. At molecular level, mRNA and protein expression 
of Non-muscle myosin IIA (NMM IIA) and RhoA increased upon shear stress exposure. 
However, when the contractility controlled by actomyosin contractility was inhibited using 
pharmacological actomyosin inhibitors, hMSCs did not exhibit markers for osteogenesis. 
Focal adhesions (immunostained for Paxillin) also increased in area and got aligned along the 
fluid flow direction (Fig. 4.14). Cell alignment and underling ECM protein was also observed 
to play a pivotal role in controlling the shear stress mediated contractility changes in the 
hMSCs. Perpendicularly aligned cells and those seeded on fibronectin or collagen I 




demonstrated significantly larger increase in contractile proteins (NMM II A and phospho-
ERK(1/2)) as opposed to cells aligned along the flow or seeded on laminin, respectively.  
Figure 4.15. FSS modulated osteogenesis in hMSCs. A. hMSCs in static condition. B. On collagen I 
or fibronectin, FSS induces increase in hMSC contractility leading to osteogenesis. C. FSS directed 
osteogenesis in hMSCs, on collagen I or fibronectin, is inhibited when cells are treated with 
pharmacological actomyosin contractility antagonists. D. On laminin, hMSCs remain multipotent, 










Hence, in conclusion, shear stress impacts on intracellular contractility, which could be 
enhanced either by cell alignment or by the ECM underneath it, and eventually the applied 
external force leads to osteogenesis. Cellular pre-stress, augmented by contractile 
components of cells, is critical for initiation of ostogenic pathways. Higher contractility in 
cells is enhanced due to applied external force and activates signaling pathways essential for 
ostogenesis. However, lower contractility does not allow shear stress-mediated osteogenesis. 
Furthermore, the failure of shear stress mediated differentiation under actomyosin 
contractility inhibition is a clear indicative of the relevance of intracellular contractility in 
fluid shear stress mediated fate determination.  
Results from focal adhesion studies suggest that tension experienced by cells at the focal 
adhesion complexes also might be undergoing alterations, depending on the alignment of the 
cells or due to preferential interaction of integrins with the ECM, resulting in change in cell 
response towards the modification in the microenvironment. Such interactions of the cells 
with the microenvironment, ECM or external forces, could change the cell characteristics, 
from the shape to the cytoskeletal arrangement, which would modulate the cellular 
contractility and the internal tension leading to activation of signaling pathways impinging on 
the fate of the stem cells.  
Understanding the exact mechanism of switch between fates based on the contractility of 
cells represents an important opportunity and path for future research. Prevention of 
osteogenic activation at lower contractility can be exploited to promote undifferentiated state 
of ―stemness‖ of hMSCs.  





5. Influencing fluid shear stress mediated-hMSC differentiation by 
controlling its contractility  
5.1. Preview 
In this chapter, the significance of cellular contractility in differentiation process will be 
elucidated. Different methodologies will be adapted to influence cell spreading mediated 
contractility of hMSCs. Subsequently, intracellular contractility and in turn fluid shear stress 
directed-lineage specification will be studied. Change in focal adhesion will also be analyzed. 
  
5.2. Introduction and objectives 
Extracellular physical factors acting at cell apex, like shear stress, or at the base of cell, like 
extracellular matrix, are intricately involved in the process of tissue development. 
Extracellular matrix varies in composition and in physical parameters, particularly, elasticity 
and topography. Such variations provide physical cues from ECM to the cells and have been 
shown to influence various biological responses of cells including proliferation, migration, 
endocytosis and differentiation, by modulating changes in their shape and actin cytoskeleton 
[19, 57, 230].  
In recent years there has been growing evidence indicating the importance of substrate 
elasticity in the stem cell differentiation process. Substrate elasticity also controls the extent 
of cell spreading. Stiff substrates (25-40 kPa) allows wider spreading of cells and soft 
substrates (8-17 kPa) limits cell spreading [16]. In both the cases, widely spreading stem cells 
undergo osteogenesis and poorly spreading cells follow adipogenesis. Besides ECM 
properties, ECM shape has also emerged to be key determinants of cellular response. ECM 





islands, with sharp geometrical features, have been found to enhance actomyosin contractility 
in hMSCs and promote osteogenesis [208].  
Just like substrate elasticity, substrate organization has also been seen to influence cellular 
response. Arrangement of substrate components, like, nanotopographies have been related to 
assembly/disassembly of adhesions and linked to cell phenotype, particularly with hMSC 
differentiation [15, 230]. Ordered nanotopographical patterns have been seen to result in 
lower cell adhesion, while disordered patterns [154, 155] and nanoscale banding (periodicity) 
allowed large adhesions to form [147]. Osteogenesis also occurred in cells on such random 
patterns [222]. Regular nanogratings have been found to cause neurogenesis in hMSCs [18]. 
Moreover, nanotopography has also been used for retention of multipotency in ESCs [150]. 
Highly ordered surfaces maintained the phenotype while random arrangement induced 
differentiation [151]. Nanoscale lattice arrangement enhanced ESC responsiveness to basic 
fibroblast growth factor (bFGF) [141]. 
Thus, cellular responses can be modulated by directing its ECM properties. In hMSCs, 
physical properties of ECM is also known to enhance osteogenesis by augmenting 
actomyosin contractility [16, 86, 215]. However, in physiology, hMSCs interact with fluid 
shear stress and ECM at the same time. Hence, it is intriguing to understand the process by 
which ECM modulated cellular contractility interplays with applied fluid shear stress. 
In previous chapters, we understood that the contractility of hMSCs alters with shear stress 
application. In this chapter, we will identify the cell response to FSS, while the cell 
contractility will be controlled by ECM properties. We will also establish the link between 
fluid flow-mediated lineage determination process and ECM modulated intracellular 
contractility.  





5.3. Experimental methods and design 
5.3.1.  Microcontact printing and design used 
Cellular contractility has been previously controlled by controlling the spreading area of cells 
[16, 133]. Micropatterns were used to control the spreading area. 
Square micropatterns of varied sizes were used ranging from 50 x 50 µm
2
 to 150 x 150 µm
2
 
(Fig. 5.1). The micropatterns were chosen according to the spreading area distribution studied 
in Chapter 3. For microcontact printing protocol, refer section 4.3.7.    
 
 
Figure 5.1. Micropatterned fibronectin squares. Scale: 50 µm 
 
5.3.2.  Topographical Substrates  
Figure 5.2. Scanning electron microscope images of Gratings (1) and Wells (2). Scale: 5 µm 
 
Previous studies suggest that hMSCs reside in nanotopographies in the order of 100 nm, 
which are found in the perivascular regions of the fenestrations formed by endothelial cells in 
the bone marrow [14]. Thus, 9 different topographies were studied to identify the varied 
cellular contractility on each of the topographies. Among them, two topographies, on which 
cells exhibited remarkably distinct contractile behavior, were chosen (Fig. 5.2): 





1) 2µm Line, 1µm Spacing, 80nm Height 
2) 1µm diameter Wells, 6.5µm Pitch, 1µm Depth 
Topography 1 is gratings of the similar order as observed in the physiological niche of 
hMSCs [14]. Topography 2 is made of wells of larger structures than the physiological range. 
Both topographies can be broadly categorized as: Anisotropic (gratings) and Istotropic 
(wells) topographies (Fig. 5.2). This categorization was done on the basis of the patterns in 
the topographies. Notably, topography 2 had similar topographical features (wells) as that 
found in the niche of the MSCs [14]. The microscale topographies were preferred over 
nanotopographies due to the ease of fabrication. The topographies were stitched together for 
immunostaining experiments. Individual topographies were made into channels for mRNA 
quantification. Planar PDMS substrates were used as controls for the experiments. 
5.3.3.  Topographical Microfluidic Chip 
Topographical microfluidic chamber was made by double casting of PDMS. Preparation of 
chamber includes surface-treatment of the wafers, making PDMS molds from the wafer, 
fabricating topographical substrates from the PDMS molds and sticking microfluidic 
channels on top of the topographical substrates.  
Figure 5.3. Schematic of process of making microfluidic channel with topographies. 
 





Before being used for fabrication of patterned PDMS, silanisation of the polycarbonate wafer 
was performed using Trichloro(1H, 1H, 2H, 2H-perfluorooctyl)silane (Sigma Aldrich) by the 
method mentioned in 3.3.2 and then washed with surfactant (0.01% TritonX 100, Sigma 
Aldrich). 1:10 ratio of curing agent to base was mixed homogenously, degassed for 30 mins 
and poured on the wafer. PDMS was cured at 80
ᴼ
C for 2 hours. PDMS was then carefully cut 
and peeled off from the wafer. 
Cut PDMS was then silanized by the method mentioned in section 3.3.2 and was used as 
wafer to make PDMS topographical substrates. 1:10 ratio of curing agent to base was mixed 
homogeneously, degassed for 30 mins and then spun coated on glass coverslips using a 
spincoater (Model WS-400BZ-6NPP/LITE from Laurell Technologies Corporation). PDMS 
wafers were carefully placed on the PDMS coated glass coverslips (~10 MPa), degassed for 
30 mins and then cured at 80°C for 2 hours. PDMS wafer was carefully peeled off from the 
PDMS coated glass coverslips to obtain topographies on PDMS coated on glass.  
Parallel plate microfluidic channels were prepared by the method detailed in 3.3.1. Channels 
were plasma treated using plasma cleaner and stuck on the topographies containing PDMS to 
fabricate microfluidic channels with topographies (Fig.5.3).  
5.3.4.  Holographic imaging 
Holographic imaging was performed to study the fluid flow regime developed in the presence 
of topographies at the base of the channels. 0.1µm polystyrene beads were flushed through 
the channels and a video stream of the beads flowing just above the topographies was 
captured by a holographic microscope (Model number: Nikon Eclipse TE2000 U) in the form 
of interference patterns and analyzed [223] to obtain the bead tracks and bead velocities at 
every time point. 





5.3.5.  Fluid flow conditions 
Channels were washed and primed by 70% ethanol and sterilized by UV treatment before 
use. 1X PBS was used to remove ethanol from the channels. Sterilized channels were then 
incubated with 20 μg/ml fibronectin (Sigma-Aldrich) for 1 hour.  
Flow conditions were same as detailed in section 3.3.4. 
5.3.6.  Immunocytochemistry, confocal imaging and quantification 
Immunocytochemistry, confocal imaging and quantification was done by the same method as 
mentioned in section 3.3.5. 
Primary antibodies used were Anti-CD44 (Abcam) at 1:500, Anti-CD90 (Abcam) at 1:500, 
Anti-CD105 (Abcam) at 1:500, Anti-Runx2 (SantaCruz Biotechnology, Inc.) at 1: 200, Anti-
Osteopontin (SantaCruz Biotechnology, Inc.) at 1:200, Anti-Osteocalcin (SantaCruz 
Biotechnology, Inc.) at 1:200, Anti-phospho-ERK (Cell Signaling Technology) at 1:500 and 
Anti-Paxillin (Cell Signaling Technology) at 1:500. Alexa Flour
®
 (Invitrogen) secondary 
antibodies were used. 
5.3.7.  Calcium signalling 
To access intracellular calcium signalling in the cells, Gcamp3, a genetically encoded high-
affinity calcium indicator was used [224]. Gcamp3 is a fusion protein, where eGFP is fused 
to M13 domain of myosin light chain kinase (MLCK) and calmodulin, and is circularly 
permuted. When calmodulin binds with calcium, it undergoes conformational change with 
subsequent increase in fluorescence of eGFP.  
hMSCs were transfected with Gcamp3 plasmid using Lipofectamine® 2000 (Invitrogen). 
hMSCs were seeded in petri-dishes at 70-90% confluency. Plasmid DNA and 
Lipofectamine® 2000 were diluted in Opti-MEM® (Invitrogen) to make transfection 





mixture. Cells were incubated in transfection mixture for 30 mins and then in Opti-MEM® 
for 3-4 hours. Medium was then changed to hMSC growth medium and cells were incubated 
overnight. Next day, transfected cells were visualized for confirmation, trypsinized and 
seeded on topographical channels. Gcamp3 intensity was monitored in shear stress 
experiencing hMSCs and analysed. 
5.3.8.  Alkaline Phosphatase Live staining 
Staining for ALP and imaging was done as per procedure in section 3.3.6. 
5.3.9.  Alizarin red S staining 
Terminal differentiation confirmation study was done according to procedure in section 3.3.7. 
5.3.10. mRNA expression profiles 
Total RNA was isolated from hMSCs, after fluid shear stress exposure, with RNeasy Mini 
Kit (Qiagen). Total RNA was reverse-transcribed with iScript
TM
 Reverse Transcription 





Supermix (Bio-Rad) on a Bio-Rad CFX96
TM
 Real-Time PCR Systems. Primers and probe 
sets for MYH2 (Non-muscle myosin heavy chain; NM_001256012.1), RHOA (RhoA; 
NM_001664.2), ALPL(Alkaline phosphatase; NM_000478), RUNX2 (runt-related 
transcription factor 2,  NC_000006.12), SPP1 (Osteopontin; NC_000004.12), 
BGLAP(Osteocalcin, NC_000001.11), CD44 (NC_000011.10), THY1 (CD90; 
NC_000011.10), ENG(CD105; NC_000009.12) and GAPDH (GAPDH; NC_000012.12) 
were purchased from AIT Biotech. qPCR was performed with following conditions: 95°C for 
30 sec, followed by 40 cycles at 95 °C for 3 sec and 58 °C for 4 sec. ΔCt was then calculated 
with respect to the loading control (GAPDH) for each sample; ΔCt gene of interest was 





normalised to that of the control (static condition) to obtain ΔΔCt. The fold change in the 
expression of the gene was calculated using the formula 2
−ΔΔCt
 [201]. 
Table 5.1. List of primer sequences used for qPCR 
Gene Forward Primer Sequence Reverse Primer Sequence 
GAPDH CTTTGTCAAGCTCATTTCCTGG TCTTCCTCTTGTGCTCTTGC 
MYH2 CAGACCAAAGAACAGGCAGA TCGCATCAATAAAGCTCTGG 
RHOA GGGAGCTAGCCAAGATGAAG TGGAGTGTTCAGCAAAGACC 
ALPL GATGTGGAGTATGAGAGTGACG GGTCAAGGGTCAGGAGTTC 
RUNX2 TTCACCTTGACCATAACCGTC GGCGGTCAGAGAACAAACTAG 
SPP1 AGGCTGATTCTGGAAGTTCTG CTTACTTGGAAGGGTCTGTGG 
BGLAP TGACGAGTTGGCTGACCA AGGGTGCCTGGAGAGGAG 
CD44 ACCCAAATCATTCTGAAGGC ACCTTCATCCCAGTGACCTC 
THY1 CCTAGTGGACCAGAGCCTTC CAGTTCACCCATCCAGTACG 
ENG CTCTCTGGGCCTTGAGTTTC ACCGTCTCTGGGTTCAAATC 
5.3.11. Inhibitor drug treatments 
Drug treatments were done as per procedure in section 4.3.7. 
To perform drug inhibitor experiments hMSCs were treated prior to fluid flow subjection 
with 25µM Blebbistatin (Myosin II inhibitor; Sigma-Aldrich) for 30 mins, 5µM Y-27632 
(Rho-associated Kinase inhibitor; Sigma-Aldrich) for 10 mins, 100 nM Cytochalasin D 
(Actin inhibitor; Sigma-Aldrich) for 30 mins, 5 µM Latrunculin A (disrupts Actin; Sigma-
Aldrich) for 1 hour, 100 nM PF573228 (prevents phosphorylation of Y397; Tocris 
Bioscience) for 30 mins and 100 nM PD0325901 (inhibits MEKK activity; Sigma-Aldrich) .   
 





5.4. Results and Discussion 
5.4.1.  Shear stress modulated-hMSC differentiation under varying spreading area 
 
 Figure 5.4. Phalloidin staining of hMSCs to represent cell spreading on fibronectin micropatterns. 
 
To access control on cell spreading area, square fibronectin micropatterns of varied sizes 
from 2,500 µm
2
 to 22,500 µm
2
 were stamped on PDMS coated glass coverslips. Image in 
fig.5.4 shows that cells on 2,500 µm
2
 were poorly spread and had less actin fibres, while 
well-developed stress fibres were formed in cells seeded on 15,625 µm
2
 squares. Thus, the 
cells in 15,625 µm
2
 patterns were in a pre-stressed condition. As can be seen, cells did not 
spread well on bigger patterns (22,500 µm
2





 square micropatterns were used.  
Fig.5.5A shows the NMM II A intensity measurements of the total protein expressed by 
single hMSC. Images and graph in fig. 5.5 (A and B) demonstrate that NMM II A 
expressions of cells in static condition, which were less spread on  2,500 µm
2
, was lesser than 
the cells, which were more spread on 15,625 µm
2
. Previously, similarly varied contractility, 
by measuring RhoA activity, has been observed by McBeath et al. in hMSC seeded on 1,024 
µm
2
 and 10,000 µm
2
.  











Figure 5.5. Myosin expression varied with spreading area. A and B. In static condition, hMSCs 
showed higher NMM II A expression when seeded on larger patterns. C and D. NMM II A expression 
increased in the widely spread cells upon shear stress exposure. 200 cells were analysed in 3 
independent experiments. Cell population was taken into consideration while calculating mRNA 
expression. MYH2 expression was normalized by GAPDH expression. mRNA expression was 
normalized by GAPDH expression. p <0.001. 
 
On applying fluid shear stress on these cells, NMM II A expression in cells on 15,625 µm
2
 
increased 2.5-fold more than the static cells, whereas there was no considerable change in the 
expression of the protein in cells 2,500 µm
2
 (fig. 5.5 (C and D)). Thus, when stress is applied 
on more contractile cells or pre-stressed cells, their contractility increases, while less 
contractile cells or with less contractility in the cytoskeleton, do not respond to the acting 
external global stress. 
However, even though cellular contractility increased upon increasing the spreading area of 
hMSCs, cells did not express differentiation markers in 48 hours for fluid flow induction (fig. 
5.6).This failure in differentiation on larger patterns could be attributed to sub-optimally 
attained basal contractility of the cells. Previous literature suggests larger spreading area of 
hMSCs for the initiation of osteogenesis [124]. However, such wide spreading of cells could 











5.4.2. Shear stress modulated-hMSC differentiation: Topographical effect 
Different topographies, as detailed in section 5.3.2, were used to manipulate intracellular 
contractility.  








Figure 5.7. Tracks of bead movement with flowing fluid over topographies. A and B. Tracks of 
individual beads (each bead signified by individual color) flowing over gratings and wells plotted in a 
3D graph. C. Box plot of average velocity of beads. 50 beads were tracked in 3 independent 




Figure 5.6. hMSCs do not exhibit differentiation on varied spreading areas facilitated by change in the 
size of fibronectin  microislands. 





To confirm the development of a laminar flow, fluid flow regimes on both the topographies 
were observed by the movement of bead flow through the channels just on top of the 
topographies. Fig.5.7 (A and B) tracks bead movements on two topographies, gratings (2µm 
Line, 1µm Space and 80nm Height) and wells (1µm diameter Wells, 6.5µm Pitch, 1µm 
Depth) in a 3D map. As can be seen, beads moved in straight lines thus advocating that 
laminar fluid flow regime was formed in both the topographies. Roughness of the bottom 
surface did not cause major turbulences in the flowing fluid. Turbulences occurred, if any, 
were not effective enough to affect the flow track of 0.1µm beads. Such feeble turbulences in 
fluid flow should not drift the cellular response from that generated by laminar flow. Plot in 
fig.5.7C shows a distribution of average velocity of several beads flowing through that 
particular topography. It suggests that there is no significant difference in the means of 
average velocities of bead movement on both the topographies. No significant variation in 
distribution width was observed. 
5.4.2.2. Cell spreading on different topographies 
Cell spreading area varied with different topographies. Fig 5.8 shows images of cell 
spreading area on both topographies. As can be seen, cell spread poorly on the anisotropic 
topographies while they were wide spread on isotropic topographies. Cells on planar PDMS 
had a wide range of cell spreading areas and spreading area of cells on each of the 
topographies appeared to be at the extremes of the distribution curve. The distribution of 
focal adhesion and the ease of the integrin attachment to the wells could be the reason for 
such varied spreading of hMSCs on the different topographies. 
Cells did not exhibit any alignment along the gratings, because of the shallow depth of the 
features (80 nm). Thus, for the ease of experiments only perpendicularly aligned gratings 
(with respect to the flow direction) were used. 














Figure 5.8. Cell spreading on topographies in static condition. A. Gratings restricted hMSCs from 
spreading. B. Wells promoted cell spreading. Arrow represents the grating direction. 100 cells were 
analysed in 3 independent experiments. p<0.01. Scale: 20µm  
5.4.2.3. Contractility changes on topographies 
Intracellular contractility was quantified by measuring total NMM II A expression of each 
cell on each topography. Fig. 5.9 shows a box plot of intensity measurements of NMM II A 
expressions of hMSCs on each topography. This graph shows that cells on planar substrate 
have wide distribution of NMM II A while the ones on anisotropically patterned substrate 
like gratings have very low expression of NMM II A and the ones on isotropically patterned 
substrates like wells have very high expression of NMM II A. Even though there is wide 
distribution of NMM II A expression on the wells, the mean of the distribution pattern is 
higher than the mean of the expressions on both planar PDMS and gratings. Varied 
expression of  NMM II A could be attributed to varied spreading areas of cells on each 
topography as observed by earlier studies [16, 133]. Thus, different topographies allow varied 
range of intracellular contractility. This hints on the alterations in the cellular mechanisms at 
the basal level, which could be manipulated further more by altering the external mechanical 









Figure 5.9. Box plot of expression of NMM II A of hMSCs on planar surface, gratings and wells. 80 cells were 
analysed in 3 independent experiments. p<0.05. 
 








Figure 5.10. Measured intracellular calcium intensity as observed after the binding of Gcamp3 
plasmid with Calcium ions post 6 hours of fluid flow exposure. 75 cells were analysed in 4 
independent expreiments. Arrow represents the grating direction. 100 cells were analysed in 3 
independent experiments. p<0.01. 
hMSCs transfected with Gcamp3 plasmid were seeded on the planar substrate, gratings and 
wells, and subjected to fluid flow. As can be seen in fig.5.10, intracellular calcium increases 
upon 6 hours of exposure to fluid flow. Fluid shear stress mediated increment in intracellular 
calcium has been seen before by Riddle et al and Stiehler et al [25], [76]. However, this 
increase in intracellular calcium was augmented when hMSCs were seeded on wells, and 
remained steady in hMSCs, which were seeded on gratings. Higher intracellular calcium 
within 6 hours of fluid flow is an indicative of the heightened cell response on wells towards 
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he change in the physical microenvironment. This also hints on the initiation in the increase 
of intracellular contractility in the cells seeded on wells.   
Intracellular calcium concentration is essential for cell signaling and subsequently impinges 
on cell proliferation and differentiation. Calcium signaling can trigger ERK1/2 signaling 
cascade, which is known to be significant for osteogenic differentiation by activating 
transcription factors, such asAP-1 family. These set of transcription factors are essential for 






Figure 5.11. ERK(1/2) phosphorylation increased in cells on wells. 90 cells were analysed in 3 
independent experiments.Arrow represents the direction of the gratings. p <0.01. 
 
To access the signaling cascade initiated as an effect of the application of fluid flow, 
phosphorylation of ERK(1/2) was also assessed after 6 hours of fluid flow. Fig. 5.11 
demonstrates fold change in pERK(1/2) intensity in hMSCs on different topographies when 
exposed to shear stress. Post fluid flow exposure, more phosphorylated ERK(1/2) was 
observed in cells on wells than the cells on gratings or planar surface. Mechanical stimuli 
have previously been reported to activate MAPK signaling cascades in cell types, varying 
from osteoblasts, epithelial cells and hMSCs [54, 235, 236]. This increment also indicates a 
possibility of increase in cell contractility. MAPK pathway also activates Runx2, a relevant 
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transcription factor involved in osteogenesis. Thus, raise in ERK(1/2) phosphorylation could 
indicate activated osteogenesis in cells seeded on wells. These results suggest that attachment 
of hMSCs with well-like microtopographies increases its basal contractility and such 








Figure 5.12. Contractility of hMSCs, measured by total protein and mRNA concentrations NMM II A 
and RhoA, increased in cells seeded on wells. 100 cells were analysed in 4 independent experiemnts. 
mRNA expression was normalised by GAPDH expression. Arrow represents the direction of the 
gratings. *p <0.01, **p<0.05. 
 
Subsequently, to evaluate the change in cell contractility, hMSCs were immunostained for 
NMM II A and Rho A after 48 hours of fluid flow. Fig. 5.12 contains images and graph 
showing fold change in intensity of protein expression on different topographies after shear 
stress exposure. Intensity quantification of the protein expressions in hMSCs showed 2.7-fold 
increase in NMM II A expression and 3.5-fold increase in RhoA expression in hMSCs seeded 
on wells, while in hMSCs seeded on gratings, there was 1.2- and 0.9-fold change in NMM II 
and RhoA expressions, respectively. These results were supported by data from genetic 










expressions have been plotted and shown as fold change in Fig.5.11B. Here, the plot shows 
3.2- and 3.9-fold rise in MYH2 and RHOA expressions respectively in hMSCs on wells, while 
1.8- and 1.1-fold change in MYH2 and RHOA expressions respectively in hMSCs on gratings. 
This amplified expression of NMM II A and Rho A, both at protein and genetic levels in cells 
on wells than the cells on gratings, directly imply an increased intracellular contractility in 
the former. Such increased expressions of RhoA and NMM II A could be an indicative of 
increased engagement of actin microfilaments with the motor proteins, leading to the 
increment in the cytoskeleton contractility, which eventually impinges on several cellular 
behaviors including stem cell differentiation.   
5.4.2.5. Fluid flow mediated changes in focal adhesions on topographies 
After recognizing the difference in cell contractility change on varied topographies, it is 
intuitive to identify the changes that focal adhesions of these cells undergo upon fluid shear 
stress application. Fig. 5.13A shows immunostained images of hMSCs on different 
substrates. As can be seen, the size of individual focal adhesion in hMSCs on gratings is 
larger than the cells on wells. Post fluid flow application, Fig. 5.13B suggests that the size of 
focal adhesion on wells increases 2.5-fold. Total number of focal adhesions in hMSCs on 
wells is ~2 times more than that in the cells on gratings (fig. 5.13C). However, there is no 
significant change in individual focal adhesion area in cells on gratings. Fig. 5.13D is a rose 
plot of the orientation of focal adhesion according to the flow direction. As can be seen, 
before fluid flow application, on wells, focal adhesions are aligned in every direction whereas 
on gratings, they are aligned in a single direction. However, after fluid flow exposure, focal 
adhesions get aligned along the flow direction on wells.  
 
 


























Figure 5.13. Alterations in focal adhesions when experiencing fluid shear stress on gratings and wells. 
A, B and C. Varied change in area and number of focal adhesions in hMSCs on gratings and wells. 
Images in inset show the zoomed image of focal adhesions of each cell.  D. Change in orientation of 
focal adhesions. 75 cells were analysed in 3 independent experiments to calculate the change in focal 
adhesion area. 90 cells were analysed in 3 independent experiments to calculate the focal adhesion 
turnover. mRNA expression was normalised by GAPDH expression. Arrow represents the direction 










These changes in focal adhesions suggest that probably, on wells, during shear stress 
application, the surface receptors receive the applied mechanical stresses, the actin 
cytoskeleton reorganizes into cortical cytoskeleton, leads to increase in focal adhesion and 
the shear of the fluid flow also causes focal adhesions to get aligned along the flow direction. 
Also, increase in contractility reinforces the focal adhesions and causes size increase. Thus, it 
is likely, that the mechanical forces of the fluid flow are being transmitted through the cell 
via the actomyosin cytoskeleton which subsequently directs the downstream signaling 
cascades. However, on gratings, since the contractility is quite low, cells are not sensitive to 
the forces acting on them in 48 hours of shear stress application.    










Figure 5.14. Early osteogenic markers (ALP and Runx2) expressions in hMSCs seeded on gratings 
and wells. A. Confocal images of hMSCs seeded on gratings and wells. B and C. Quantification of 
total protein and mRNA concentrations of early markers. 90 cells were analysed in 3 independent 
experiments. mRNA expression was normalised by GAPDH expression. Arrow represents the 










Similar to the results from chapter 3, shear stress mediated differentiation on topographies 
was assessed at early, late and terminal phases of differentiation. Runx2 and ALP were used 
for early markers, OPN and OCN were used for late markers and Alizarin Red S staining was 
done for terminal differentiation. Fig.5.14 depicts the fold change in expression of early 
markers (Runx2 and ALP) of osteogenic differentiation by measuring the intensity of protein 
expression. On wells, expression of Runx2 and ALP increased 3.5-fold and 3.2-fold 
respectively, whereas, on gratings, expression of Runx2 and ALP displayed no considerable 
change. These results were validated by amount of mRNAs transcribed by the cells on both 
topographies. As can be seen in Fig 5.14B, mRNA expression of RUNX2 and ALPL on wells 
were 2.6-fold and 3.5-fold respectively, while there is only 1.2-fold and 1.2-fold change in 









Figure 5.15. Late osteogenic markers (Osteopontin and Osteocalcin) expressions in hMSCs seeded on 
gratings and wells. A. Confocal images of hMSCs seeded on gratings and wells. B and C. 
Quantification of total protein and mRNA concentrations of late markers. 75 cells were analysed in 4 
independent experiments. mRNA expression was normalised by GAPDH expression. Arrow 











Fig.5.14 shows the change in expression of late markers (Osteopontin and Osteocalcin) of 
osteogenic differentiation in cells on both topographies. On shear stress application, OPN and 
OCN expression in cells on wells augmented 3.2-fold and 3.3-fold, respectively. However, in 
cells on gratings, late marker expression demonstrated no considerable change. mRNA 
expressions of SPP1 and BGLAP on wells increased 4-fold and 2.9-fold upon shear stress 
exposure, respectively, while only on gratings, the mRNA levels of the markers remained 
unaltered under fluid flow. 
Fluid flow directed terminal differentiation of hMSCs was ascertained by staining the cells 
with Alizarin Red S. Cells were first subjected to 48 hours fluid shear stress and then cultured 
in static condition in differentiation medium for 5 days. Fig.5.16 depicts that cell on wells, 
after fluid flow exposure stained positive for the extracellular calcium deposition. As can be 
seen, the stained area is larger in channels with wells than with planar surface. However, cells 
on gratings were stained negatively for Alizarin Red S staining.  
These results suggest that upon shear stress exposure, hMSCs undergo osteogenesis on wells, 
isotropic substrate, while there is no sign of differentiation in cells on gratings, anisotropic 
substrate. Differentiation on wells could be attributed to the increased spreading area and 
contractility of the cells in the presence of fluid flow. Pre-stress generated in cells due to 
wider spreading area of the cells prepare hMSCs for ostoblastic differentiation on wells. 
Restricted spreading and reduced intracellular contractility in hMSCs on gratings prevents the 
activation of differentiation even in the presence of external forces. Thus, pre-stress is a 
significant factor in the fluid shear stress directed stem cell fate.  





Figure 5.16. Alizarin Red S staining to determine terminal differentiation of hMSCs on topographies. 
 
Amount of hMSCs differentiation quantified by Osteopontin expression on planar substrate 
and wells was also quantified and plotted in fig.5.17. As can be seen, upon fluid flow 
exposure, only 40% of the cells differentiated on planar substrate and it increased to 70% on 
wells. This augmented differentiation could be due to increase in intracellular contractility. 
Such an increase in cell contractility might be preparing the cells to initiate osteogenesis on 
the reception of the very first external stimulus. Thus fluid shear stress, an external force, 
might just be propelling hMSCs through the process. This observation iterates the relevance 
of requirement of an optimum contractility level for an external force to initiate the process of 
differentiation in these cells. Conditions, where the microenvironment influences the cell to 
maintain its contractility below that optimal level, prevent the cells from activating the 
processes which lead to their differentiation.    





Figure 5.17. Percentage of hMSCs differentiating on wells were higher than that on planar surface. 
200 cells were analysed in 4 independent experiments. p <0.001. 
 









Figure 5.18. Multipotency markers, CD44, CD90 and CD105 reduced in cells on wells and 
maintained steady concentration in cells on gratings. 75 cells were analysed in 3 independent 
experiments. mRNA expression was normalised by GAPDH expression. Arrow represents the 
direction of the gratings. *p <0.01, **p<0.05. 
 
The fate of the hMSCs exposed to fluid shear stress while being cultured on wells was 
identified in the previous sections. It is now relevant to ascertain the fate of these cells while 











markers. After being subjected to fluid shear stress for 48 hours, hMSCs were immunostained 
for multipotency markers, CD44, CD90 and CD105. Fig.5.18 represents fold change in the 
expression of multipotency markers after 48 hours of fluid shear stress exposure to hMSCs 
seeded on different topographies. Plot in fig.5.18B shows that, upon fluid flow, multipotency 
of hMSCs reduced on wells, while it remained the same on gratings. mRNA expression 
plotted in fig.5.18B also supported the protein expression results. This suggests that hMSCs 
remain multipotent on gratings even after an external stress is applied on it, while they start 
differentiating on wells as soon as they are subjected to an external force. This could be 
explained by the augmentation in differentiation potential of hMSCs on wells and 
augmentation of multipotent nature of hMSCs on gratings. Failure of fluid shear stress to 
activate differentiation in hMSCs on gratings could be attributed to the lowered contractility 
in the cells due to cell spreading area.  
5.4.2.8. Effect of actomyosin and focal adhesion inhibitors 
To attain a better understanding of the role of actomyosin contractility in the phenomenon, 
cells were treated with several cytoskeletal contractility inhibitors. Blebbistatin (Myosin II 
inhibitor; Bbstn), Y-27632 (ROCK inhibitor), Cytochalasin D (Actin inhibitor; Cyt D) and 
Latrunculin A (Actin inhibitor; Lat A) were used to disrupt actomyosin contractility and 
hMSCs with inhibited actomyosin cytoskeleton were subjected to fluid shear stress. Runx2 
and Osteopontin expressions were measured and plotted as Fig. 5.19. When subjected to fluid 
flow in the presence of actomyosin inhibitors, as opposed to untreated cells, hMSCs, on wells 
and gratings, did not express osteogenic markers (fig. 5.19 (A and B)).  
When FAK or ERK(1/2) was inhibited from getting phosphorylated using PF573228 (Y397-
pFAK inhibitor) or PD0325901 (pERK(1/2) inhibitor), respectively, fig. 5.19 (C, D, E and F) 
suggests that even after fluid shear stress exposure, cells, seeded either on wells or on 





gratings, did not express Osteopontin. Fig. 5.19 (G and H) depicts that total number of focal 















Figure 5.19. Effect of inhibitors on fluid shear stress mediated fate upon different topographies. A and 
B. Differentiation of cells in the presence of inhibiting drugs. C and D. Alteration in osteogenesis on 
different topographies when subjected to fluid flow in the presence of MEKK inhibitor. E and F. 
Alteration in hMSC osteogenesis on different topographies when subjected to fluid flow in the 
presence of pFAK inhibitor. G and H. Focal adhesion changes in cells as an effect of actomyosin 
inhibitors. 100 cells were analysed in 3 independent experiments to calculate the effect of drugs on 
fluid shear stress mediated differentiation. 75 cells were analysed in 3 independent experiments to 
identify MEKK effect. 90 cells were analysed on 3 independent experiments to study the effect of 











These results suggest that hMSCs do not undergo differentiation process when fluid shear 
stress is applied on cells while their intracellular contractility or FAK phosphorylation is 
inhibited. From the above observations, we understand that upon subjection to external force, 
NMM II A phosphorylation pulls on actin microfilaments and increases cellular contractility. 
This augmented contractility acts on focal adhesions, recruits more focal adhesion proteins 
leading to formation of more focal adhesions and eventually leading to activation of genes 
specific to osteogenesis in hMSCs. Inhibition in any of these processes could lead to 
prevention of the shear stress mediated osteoblastic differentiation. These results emphasizes 
even further on the pivotal role played by the actomyosin cytoskeleton in the transmission of 
fluid shear forces, detected at the apex of the cell, to the other cell processes and 
subsequently, directing the fate of the cells. However, optimal cell contractility also appears 
to be relevant in the decision of fate determination directed by fluid flow.  
5.5. Conclusions 
Bone marrow consists of fenestrated sinusoidal capillaries, which form the niche of hMSCs 
[2]. Typically, these fenestrations, formed by endothelial cells of the sinusoidal walls [3], are 
100 nm in diameter [14], indicating that hMSCs may inherently be residing in regular 
topographies. Several in vitro studies also suggest that topographical features control MSC 
growth and fate. Knowing that, physiologically, cellular responses are majorly controlled by 
their extracellular environment, it is important to understand how the ECM influenced 
contractility of stem cell responds to fluid shear stress. 
In this chapter, we have identified topographical features that influence intracellular 
contractility by modulating the cell spreading area. Cells spread widely on wells (isotropic 
topography) but were poorly spread on gratings (anisotropic topography). Immunostaining of 
hMSCs on each topography showed that NMM II A expression was higher on wells and 





lower on gratings. Upon shear stress application, this intracellular contractility increased on 
wells, while it, invariably, remained same on gratings. On fluid flow, RhoA and intracellular 
Ca
2+
 concentrations also augmented in cells on wells. Phosphorylation of ERK(1/2) also 
increased upon shear stress application in those cells. Focal adhesion number increased in 
cells on wells. Also, focal adhesions got aligned along the fluid flow (Fig. 5.19). Eventually, 
cells, on wells, were found to be positive for Osteogenic markers (ALP, Runx2, Osteopontin 
and Osteocalcin) both at genetic and protein levels, upon 48 hours of shear stress exposure. 
However, cells, on gratings were positive for multipotency markers, CD44, CD90 and 
CD105. And, when actomyosin contractility or phosphorylation of ERK(1/2) or FAK was 
hindered using specific inhibitors, hMSCs donot undergo osteogenesis, even after external 
force application.  
In conclusion, upon shear stress application, contractility of hMSCs increases, which 
impinges on the focal adhesion area and alignment. This suggests that there is a pre-stress 
generated in cells seeded on wells. These intracellular changes influence actomyosin 
filaments and stimulate osteogenic differentiation-related genes and activate osteogenesis. 
However, for osteogenesis initiation upon application of external forces, hMSCs need to 
attain higher contractility, while lower cellular contractility keeps hMSCs multipotent. This 
also enables us to hypothesize that to limit stem cell differentiation, cellular contractility 
needs to be reduced to an amount that allows cell proliferation as opposed to a level where 
the cells become rounded and quiescent, eventually, leading to adipogenesis. Thus, optimum 
intracellular contractility needs to be generated to trigger crucial metabolic and biochemical 
signaling pathways to attain the threshold needed for active differentiation (Fig. 5.19). Thus, 
cellular contractility and tension is a relevant modular mechanism for the fate of hMSC. 
 
















Figure 5.20. FSS mediated osteogenesis in hMSCs in 48 hours of flow induction. A. On gratings, FSS 
had no effect on hMSCs and they remain multipotent. B. On wells, FSS induced increase in 
intracellular Ca
2+
 and cell contractility leading to osteogenesis. C. Pharmacological antagonists of 
FAK or ERK(1/2) phosphorylation or actomyosin contractility inhibit FS directed osteogenesis in 
hMSCs on wells. 
 
From our study, it is quite clear that ECM directed cell responses to fluid shear stress are 
different on different substrates and must be taken into account for optimal control of stem-
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6.  Conclusions and future work 
6.1. Conclusions  
hMSCs have been posed as an attractive candidate for stem cell-based therapies. However, a 
deeper understanding of the response of stem cells towards its niche is required to develop 
improved strategies for stem cell therapies. One such effort is to understand the impact of 
mechanical factors of the stem cell environment on the process of their survival, self-renewal 
and fate determination.  
Adult hMSCs reside in the endothelial sinusoidal fenestrations of bone marrow in the long 
bones along with other cells of the tissue. When these long bones undergo mechanical 
loading, interstitial fluid flows through the bones and creates shear stresses of between 0.8-3 
Pa. Thus, the hMSCs not only undergo cell-cell interactions and cell-extracellular matrix 
interactions but also experience fluid shear stresses. In vitro studies have demonstrated that 
intracellular contractility, mediated by cell cytoskeleton and small Rho GTPases, changes 
when shear stress is applied. hMSC differentiation is also modulated by fluid shear stress. 
Hence, this thesis has focused on elucidating the role of fluid shear stress in directing the 
contractility and lineage specification of hMSCs and comprehending the modular 
mechanisms involved in the phenomenon. 
In Chapter 3, the differentiation lineage followed by the hMSCs under the influence of shear 
stress has been observed. Immunostaining of several osteogenic markers, Alkaline 
Phosphatase, RunX2, Osteopontin and Osteocalcin, suggested that under the effect of fluid 
flow, hMSCs follow osteogenic lineage. These results are supported by quantification of 
genetic expression done by qPCR. Terminal decision of FSS mediated osteogenesis in 
hMSCs was taken as early as 48 hours. Thus, FSS (Fluid shear stress) allows a specific fate 
response in hMSCs. Interestingly, in a range of 1-1.5 Pa, which is within physiological shear 
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rate limits [20], hMSCs underwent maximum osteogenesis. These variations in the 
differentiation process at different shear rates could be  explained by limited mechanical 
stresses applied on the cells at reduced fluid flow rates and reduced ligand-receptor 
interactions between cells and the secreted growth factors, thus, diminishing the paracrine 
effect. Intuitively, 37.5% increase in the percentage of differentiating cells was obtained upon 
changing the flowing fluid, from growth medium to osteogenic induction medium. 
Remarkably, hMSCs underwent FSS mediated osteogenesis only on fibronectin and collagen 
I, while they maintained their multipotency on laminin. These results suggest that chemical 
inducers and mechanical factors coordinate to accelerate the process of osteogenesis initiated 
by an external force, which is quite understandable as both biochemical and physical factors 
contribute to form in vivo stem cell niche. Comprehensive understanding of the combinatorial 
effect of the chemical and mechanical factors regulating FSS effects on hMSCs will help us 
develop better tissue engineering platforms and stem cell based therapeutics.  
In chapter 4, the shear stress mediated cellular changes related to contractility of the hMSCs 
was studied. Morphological changes in the cells demonstrated lamellipodial alignment along 
the flow direction, marking the onset of cell alignment in the direction. Further, cell shape 
changed from a less contractile form (square) to a more contractile form (elongated) and the 
trend was followed at different shear rates. Elastic modulus of cells measured post 48 hours 
shear stress application was comparable to that of osteocytes. At molecular level, to 
understand the role of cellular contractility under shear stress, Non-muscle myosin IIA 
(NMM IIA) and RhoA was immunostained in hMSCs and was found to be increasing with 
time. However, on inhibition of actomyosin contractility of the cells using pharamacological 
antagonists (like, Blebbistatin, Y-27632, Cytochalasin D, Latrunculin A), hMSCs did not 
undergo osteogenesis, thus indicating the relevance of cellular contractility in FSS mediated 
osteogenesis. The failure of shear stress mediated differentiation under actomyosin 
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contractility inhibition clearly suggests that cellular contractility is the link between shear 
stress and stem cell fate regulated by FSS. Focal adhesions area increased and aligned along 
the flow direction implying the reinforcement of contractile proteins (cell cytoskeleton) along 
the flow direction. Cell alignment with respect to the fluid flow direction and ECM ligands 
also controlled the contractility of the cells. The conditions where higher contractility was 
generated upon shear stress application (cell aligned perpendicular to the flow or residing on 
fibronectin or collagen I) initiated osteogenesis in cells on fluid shear stress application. 
Thus, cellular pre-stress, modulated by intracellular contractility, is essential for activating 
genes specific for osteoblastic differentiation coordinated by FSS. Understanding the exact 
mechanism regulating these individual modules is an intriguing opportunity for future 
research. Regulation of differentiation and retention of multipotency in the presence of fluid 
flow is a significant area for research to allow stem cell based therapeutics to prosper. 
In chapter 5, ECM controlled contractility was modulated by FSS to comprehend the fate 
decision of hMSCs. Two different topographies, Isotropic (Wells; 1µm diameter Wells, 
6.5µm Pitch, 1µm Depth) and Anisotropic (Gratings; 2µm Line, 1µm Space and 80nm 
Height), allowed varied levels of expression of NMM II A in hMSCs. Cells were more 
contractile on wells than gratings. On shear stress application, the intracellular contractility of 
cells on wells increased, indicated by increased intracellular Ca
2+
, phosphorylated ERK(1/2) 
NMM II A and RhoA, while it remained invariably same in cells on gratings. Focal adhesions 
also demonstrated increased area on wells than gratings. Subsequently, FSS mediated 
osteogenesis occurred in hMSCs on wells while the cells on gratings remained multipotent. 
And, when intracellular contractility or phosphorylation of ERK(1/2) or FAK was inhibited 
by pharmacological inhibitors, hMSCs did not undergo FSS mediated osteogenesis. Thus, an 
optimal contractility of cells is needed, which in this case was being modulated by ECM 
topographies. Only cells with higher contractility can be triggered to undergo osteogenesis by 
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the global forces like shear stress. Cells with lower contractility retain their multipotency. 
Hence, it can be postulated that an optimum intracellular contractility is required to stimulate 
metabolic and biochemical signaling pathways essential for retaining multipotency or 
activating differentiation in hMSCs. From our study, it is evident that variations occur in 
ECM controlled cell response upon activation by shear stress and a detailed study in this field 
is needed in future to enable optimal control over stem-cell expansion and differentiation. 
The results, here, suggest that the surface receptors at the cell apex receive the mechanical 
forces applied by the fluid shear stress and transmit it to the cell processes via the cellular 
cytoskeleton. It can also be hypothesized that integrins acting as the mechanosensors to sense 
the topography of the ECM beneath the cells and subsequently influencing the contractile 
mechanisms of the cells. The modulation of the actomyosin cytoskeleton due to the fluid 
shear forces received by the surface receptors attenuates the cell contractility controlled by 
the ECM topographical signals and regulates the fate of hMSC. 
Taken together, it can be postulated that fluid shear stress triggers the calcium signaling 
pathway and MAPK pathway via ERK(1/2) phosphorylation subsequently increasing the 
internal cellular contractility by increasing the concentration of contractile proteins (NMM II 
A and RhoA) in hMSCs. Increased contractility impinges on FAK phosphorylation and 
increase in focal adhesion area size and alignment. Stimulation of ERK(1/2) phosphorylation 
and increased cellular contractility influence the osteogenic differentiation-specific genes and 
initiate osteogenesis in hMSCs. This process is augmented when cells have increased 
contractility attributed to cell alignment or ECM architecture or chemistry. Hence cellular 
contractility is a crucial determinant of stem cell fate in fluid flow systems. 
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6.2. Future work 
With this thesis, we have established some basic knowledge indicating the interplay between 
the modular mechanisms of cell with each other in order to control the fluid shear stress 
mediated stem cell differentiation. We have shown that fluid shear stress impinges on stem 
cell contractility to direct its fate. This thesis provides an important platform to control the 
contractility and subsequently the fate of the hMSCs. Thus, we have opened up an avenue of 
further interesting questions:  
1. In chapter 3, we found that the cells undergo fluid shear stress mediated 
differentiation in a regime of 1-1.5 Pa. This observation has kindled a very important 
question about the potential of mechanical forces, like fluid shear stress, in hMSC 
differentiation. It is also intriguing to comprehend the interplay of chemical factors 
with the mechanical factors in course of stem cell differentiation. This can be studied 
by identified the paracrine factors released by hMSCs in the flowing fluid by mass 
spectromentry. 
2. In chapter 3, we also realised that the fate of hMSCs varied while being seeded on 
different ECM proteins. It is rather important to understand the mechanism underlying 
such differential behaviour of hMSCs on different ECM proteins. It would be 
interesting to look at the integrins expressed by hMSCs, the predominant intergrins 
interacting with each of these ECM proteins and whether these interactions alter upon 
fluid flow application. Understanding the mechanisms which help the hMSCs to 
retain their multipotency on laminins would help in developing a better system for 
tissue engineering purposes. 
3. In chapter 3 and 5, in independent experiments, we have observed that hMSCs tend to 
remain multipotent even after shear stress exposure, while seeded on laminin or 
gratings. These experiments have been performed with fluid flow application for 48 
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hours. To develop better tissue engineering applications, it would be relevant to apply 
fluid shear stress on hMSCs for longer durations, while they are seeded on laminin or 
gratings. This would help us understand whether hMSCs are undergoing any lineage 
specification later or the ECM properties help them to remain multipotent for longer 
durations. 
4. In chapter 4, the orientation of cell alignment has been identified to be significant for 
hMSC differentiation by fluid flow exposure. It can be speculated that this difference 
in cell response is attributed to the difference in force experienced by the cell due to 
the varied alignment of actomyosin cytoskeleton in the two conditions. Testing the 
hypothesis would help us delve deeper into the role of cell contractility in stem cell 
differentiation.  
5. In chapter 4 and 5, we have explored that contractility plays a pivotal role in fluid 
shear stress directed osteogenesis in hMSCs. From molecular biology point of view, it 
is significant to realize the molecular pathways controlling the phenomenon. 
Performing more experiments to inhibit the specific signaling cascades will help in 
distinguishing the relevance of those signaling pathways in this process. 
6. In chapter 5, the effect of combination of ECM topography and fluid shear stress on 
hMSC fate has been questioned. Upon understanding the different fate chosen by 
hMSCs due to the topographies, it is also relevant to carefully segregate and examine 
the significance of the two components (topography and fluid shear stress) in the 
phenomenon. This can be done by performing varying the applied shear stress values 
and application durations on the cells seeded on chosen topographies. Adding more 
static controls to the experiment will also provide a better understanding of the 
phenomenon. 
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Since hMSCs are used for tissue engineering purposes, the outcomes in this study will have a 
major impact on designing materials for stem cell culture needed for tissue engineering 
therapies. This study will also be helpful in controlling the fate of the cells seeded in the 
scaffold grafted in the patients. Plenty of questions regarding cellular biomechanics can thus 
be addressed using the strategies opted in this thesis.  
We have also established the dependency of fluid shear stress on cellular contractility while 
leading to osteogenesis. However, the study does not include the stress mediated control into 
lineages other than osteogenic lineage. Further studies need to be done to elucidate on such 
aspects. It is hoped that the studies here have revealed some modular mechanisms involved in 
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8. Appendix A1 
 
Cy-5-Fibronectin Conjugation 
Fluorescent dye conjugated fibronectin is helpful in authenticating that the fibronectin 
micropatterns have been properly transferred from the PDMS stamps onto the desired 
substrate. Fibronectin solution (1 mg/ml; Sigma-Aldrich) needs to be dialysed prior to 
conjugation to remove Tris Buffer. Fibronectin was first poured into a dialysis membrane 
(suitable for MW>10kDa; Spectrum Laboratories) and suspended overnight at 4ºC in 500ml 
Na2CO3solution (pH ~7.4). Following morning, dialysis membrane was placed in fresh 
Na2CO3solution for 3hours. Fibronectin was then aspirated from the membrane and 
transferred it into an Eppendorf tube along with the dye. The solution was incubated for 30 
mins at room temperature while slightly shaking the tube at 10 min intervals. Next, the dye-
fibronection solution was transferred into a fresh dialysis membrane. To remove the 
unconjugated dye, the membrane with dye-fibronection solution was dipped in 500ml PBS 
and incubated overnight at 4ºC. Next morning, the membrane was placed in fresh PBS 
solution for another 3 hours. Lastly, the solution was aspirated out of the membrane and 
stored in aluminium foil covered tube at 4ºC.  
